Document:

Execution
Copy

 

OPTION
AGREEMENT

 

by
and among

 

LOGICAL
CHOICE CORPORATION,

 

THE
MAJORITY SHAREHOLDERS,

 

K
LASER TECHNOLOGY, INC.

 

as
Shareholders’ Representative,

appointed
pursuant to the Share Purchase Agreement

 

and

 

VERT
CAPITAL CORP.

 

January
31, 2015

 

    	 

    	 

    

 

Table
of Contents

 

	 	 	 	 	Page
	 	 	 	 	 
	ARTICLE
    I OPTION TO PURCHASE OPTION SHARES	 	1
	 	 	 
	 	1.1	The
    Option, the Option Shares and Additional Preferred Stock	 	1
	 	1.2	Exercise
    of the Option	 	2
	 	1.3	Option
    Price	 	 2
	 	1.4	Closings	 	2
	 	 	 	 	 
	ARTICLE
    II AGREEMENTS OF THE PARTIES	 	3
	 	 	 
	 	2.1	Proposed
    Acquisitions and Issuance of Acquisition Securities	 	3
	 	2.2	Required
    Consent	 	7
	 	2.3	Certain
    Definitions	 	7
	 	2.4	Agreements,
    Filings, Financial and Other Information	 	7
	 	2.5	Lock
    Up Agreements	 	7
	 	2.6	Stock
    Options	 	7
	 	2.7	Approvals	 	7
	 	2.8	Registration
    Rights	 	8
	 	2.9	Change
    of Name	 	8
	 	 	 	 	 
	ARTICLE
    III GENERAL PROVISIONS	 	8
	 	 	 
	 	3.1	Publicity	 	8
	 	3.2	Notices	 	9
	 	3.3	Entire
    Agreement	 	9
	 	3.4	Incorporation
    by Reference	 	9
	 	3.5	Waivers
    and Amendments	 	9
	 	3.6	Exhibits
    and Schedules	 	10
	 	3.7	Headings	 	10
	 	3.8	Counterparts	 	10
	 	3.9	Construction
    and Interpretation	 	10
	 	3.10	Assignment	 	10
	 	3.11	Parties
    in Interest	 	10
	 	3.12	Severability	 	10
	 	3.13	Specific
    Performance	 	10
	 	3.14	Governing
    Law; Forum	 	10

 

List
of Exhibits

 

	Exhibit
    A	List
    of Majority Shareholders
	Exhibit
    B 	Series
    C Certificate of Designations
	Exhibit
    C	Restated
    Certificate of Incorporation of the Company
	Exhibit
    D	Capitalization
    of the Company

 

    	(i)

    	 

    

 

OPTION
PURCHASE AGREEMENT

 

OPTION
AGREEMENT (this “Agreement”), dated as of January 31, 2015, is made and entered into by and among:

 

K
LASER TECHNOLOGY, INC., a Taiwan corporation (“K Laser”); the other Persons who are listed as the shareholders
of EVEREST DISPLAY, INC., a corporation organized under the laws of Taiwan (“EDI”) on Exhibit
A (“Majority Shareholders”); the Participating Minority Shareholders (as defined in the Share Purchase
Agreement); LOGICAL CHOICE CORPORATION, a corporation organized under the laws of State of Nevada, USA (the “Company”
or the “Parent”) and VERT CAPITAL CORP., a corporation organized under the laws of State of Delaware,
USA (the “Vert”).

 

K
Laser, the other Persons who are listed as Majority Shareholders on Exhibit A, and the Participating Minority Shareholders
(as defined in the Share Purchase Agreement) are hereinafter collectively referred to as the “Option Holders.”

 

K
Laser shall be appointed as Shareholders’ Representative pursuant to the Share Purchase Agreement.

 

WITNESSETH:

 

WHEREAS,
upon the terms, in the manner and subject to the conditions set forth in a share purchase agreement, dated as of January 31,
2015 (the “Share Purchase Agreement”) among the Option Holders, the Company, K Laser Technology, Inc., a corporation
organized under the laws of Taiwan, Boxlight Display Inc., a corporation organized under the laws of Taiwan and Vert, whereby
the Option Holders have agreed to sell to the Company and the Company has agreed to purchase from the Option Holders, the “Subject
Shares”; and

 

WHEREAS,
upon the terms, in the manner and subject to the conditions set forth in this Agreement the Company has agreed to grant to the
Option Holders an option to make an investment in shares of Series C Preferred Stock (as hereinafter defined) of the Company.

 

NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be
legally bound hereby, the Parties hereto hereby agree as follows:

 

Article
I

OPTION
TO PURCHASE OPTION SHARES

 

1.1
The Option, the Option Shares and Additional Preferred Stock.

 

(a)
Option. On the terms and subject to the conditions set forth in this Agreement, for USD$10.00 and other good and valuable
consideration, the Company hereby grants unto the Option Holders an irrevocable and unconditional right and option (the “Option”)
to purchase, an aggregate number of (i) shares of Series C Preferred Stock (as defined in the Certificate of Designations annexed
hereto as Exhibit B and made a part hereof (the “Series C Certificate of Designations”)) authorized
in the Series C Certificate of Designations to be issued pursuant to the terms of this Agreement and (ii) such additional shares
of Series C Preferred Stock as shall be required to be issued to pay the dividends, if any, paid or payable on outstanding shares
of Series C Preferred Stock (collectively, the “Option Shares”).

 

(b)
Terms of the Option Shares. The Option Shares shall have the rights, privileges, designations and preferences of the Series
C Preferred Stock of the Company that are set forth in the Series C Certificate of Designations.

 

    	1

    	 

    

 

1.2
Exercise of the Option.

 

(a)
Exercise of the Option. At the Closing (as defined in the Share Purchase Agreement) and upon the payment of the Purchase
Price pursuant to the Share Purchase Agreement on the Closing Date: (i) each of the Option Holders shall automatically exercise
the Option in full, and the Option shall be deemed to be automatically exercised in full by each of the Option Holders, with no
partial exercise of the Option permitted, and (ii) , upon the occurrence of a Liquidity Event (as defined in the Series C Certificate
of Designation) all of the Option Shares shall automatically convert into that number of shares of Common Stock of the Company
equal to the Automatic Conversion Shares (as defined in the Series C Certificate of Designation).

 

(b)
Method of Exercise of Option. On the Closing Date, the Company or the “Purchaser” under the Share Purchase
Agreement shall make payment of the Purchase Price in cash pursuant to such Share Purchase Agreement, each Option Holder shall
pay his or its pro-rata portion of the Option Price referred to in Section 1.3 below to the Company in cash.

 

(c)
Allocation of Option Shares. Upon exercise of the Option, the Option Shares shall be issued to each of the Option Holders
in accordance with Schedule 1.2(c) of this Agreement.

 

1.3
Option Price.

 

(a)
Upon exercise of the Option pursuant to Section 1.2(a), the Option Holders, as a group, shall pay the Company a purchase price
equal to the Purchase Price (the “Option Price”).

 

(b)
Each Option Holder shall pay his, her or its allocable pro-rata share of the Option Price in accordance with either Section 1.2(b)(i)
or Section 1.2(b)(ii) above, depending upon the method by which the Purchase Price is paid by the Purchaser or the Company. The
Option Price for each Option Holder shall be calculated by multiplying the total Option Price by a fraction, (x) the numerator
of which is the number of the Subject Shares sold to the Company under the Share Purchase Agreement by each Option Holder, and
(y) the denominator of which is the number representing all of the Subject Shares sold by the Option Holders to the Company under
the Share Purchase Agreement.

 

(c)
The Option Price shall be paid by each of the Option Holders, either in cash by wire transfer of immediately available funds to
a bank account designated by the Company, or by application of such Option Holder’s allocable portion of the Purchase Price
from the sale of the Subject Shares under the Share Purchase Agreement, in accordance with the provisions of Section 1.2(b)(ii)
above.

 

1.4 Closings.

 

(a)
Upon the terms and subject to the conditions set forth herein, exercise of the Option and the closing of the issuance and sale
and the purchase of the Option Shares and related transactions under this Option Agreement (the “Closing”)
will take place at 10:00 a.m., Taiwan time, on a date which shall be simultaneous with the Closing Date of the transactions contemplated
by the Share Purchase Agreement. The Closing shall be held at the offices of White & Case, attorneys at law, and United States
counsel to the Everest Group and the Option Holders in Palo Alto, California, unless another place is agreed to in writing by
the parties hereto, and the actual date of the Closing is hereinafter referred to as the “Closing
Date.” Notwithstanding the foregoing, in no event shall the Closing of the exercise of the Option be earlier
than or later than the Closing Date under the Share Purchase Agreement, and, unless otherwise agreed to by the Company and the
“Shareholders Representative” (as defined in the Share Purchase Agreement), in no event shall such Closing
of the exercise of the Option be later than the March 31, 2015 “Outside Closing Date” under the Share Purchase
Agreement.

 

    	2

    	 

    

 

(b)
Notwithstanding anything to the contrary, express or implied, contained in the Transaction Documents (as defined in the Share
Purchase Agreement), the obligations of the parties to consummate the transactions contemplated by the Share Purchase Agreement
and this Agreement shall be subject to the simultaneous closings of the Share Purchase Agreement and this Option Agreement, including
the payment of the Purchase Price under the Share Purchase Agreement, the payment of the Option Price and the exercise in full
of the Option.

 

Article
II

AGREEMENTS
OF THE PARTIES

 

2.1
Proposed Acquisitions and Issuance of Acquisition Securities. The Parties hereto acknowledge that Vert and the Company represent
and warrant to the Option Holders as follows:

 

(a)
Capitalization of the Company. As at the date of this Agreement, the Company is authorized by its Restated Articles of
Incorporation in the form of Exhibit C annexed hereto, to issue an aggregate of two hundred and fifty million (250,000,000)
shares of capital stock, $0.0001 par value per share, of which two hundred million (200,000,000) shares are designated as common
stock, of which one hundred and fifty million (150,000,000) shares are designated as Class A voting common stock (the “Company
Class A Common Stock”) and fifty million (50,000,000) shares are designated as Class B non-voting common stock (the
“Company Class B Common Stock” and together with the Company Class A Common Stock, the “Company Common
Stock”) and fifty million (50,000,000) shares are designated as preferred stock (the “Company Preferred Stock.”
The Company Common Stock and the Company Preferred Stock is collectively referred to as the “Company Capital Stock”).
As at the date of this Agreement, the record and beneficial owners of the Company Capital Stock and number of shares and class
of Company Capital Stock owned by each of the Persons who are set forth on Exhibit D annexed hereto and made a part
hereof. As at the date of this Agreement, an aggregate of (i) twenty-five million six hundred thousand (25,600,000) shares of
Company Class A Common Stock are issued and no Company Class B Common Stock is issued.

 

(b)
Acquisition of Globisens. As of the date of this Agreement, the Company has entered into a share exchange agreement to
acquire, immediately following consummation of a Liquidity Event, 100% of the share capital of Globisens, Ltd., an Israeli corporation
(“Globisens”) in consideration for the payment of $2,500,000 in cash, plus the issuance of $2,750,000 of Company
Common Stock, (valued at the initial per share price of Company Common Stock issued in the Company IPO) but in no event less than
four and 375/1000 percent (4.375%) of the Fully-Diluted Common Stock of the Company (as defined in the Share Purchase Agreement)
on the date of the Liquidity Event. The closing of the acquisition of Globisens shall occur promptly following the acquisition
by the Company of the Subject Shares under the Share Purchase Agreement and the exercise of the Option and issuance of the Option
Shares pursuant to this Agreement.

 

(c)
Acquisition of Genesis. As at the date of this Agreement, Vert has assigned and transferred 100% of the membership interests
in Genesis Collaboration LLC, a Georgia limited liability Company (“Genesis”) to the Company and the
Company has agreed to issue to the four former members of Genesis 1,000,000 shares of Series B preferred stock of the Company
(the “Series B Preferred Stock which is automatically convertible into four percent (4%) of the Fully-Diluted Common
Stock of the Company (as defined in the Share Purchase Agreement) on the date of the Liquidity Event. The closing of the acquisition
of Genesis shall occur promptly following the acquisition by the Company of the Subject Shares under the Share Purchase Agreement
and the exercise of the Option and issuance of the Option Shares pursuant to this Agreement, and the acquisition of Globisens
contemplated by Section 2.1(b) above.

 

    	3

    	 

    

 

(d)
Issuance of Series A Conversion Shares. Following consummation of the Company IPO, the Company intends to issue to a trustee
designated by Vert, a total of 2,500,000 shares of the Company’s Series A Preferred Stock which is to be converted into
2,500,000 shares of Company Common Stock (the “Series A Conversion Shares”). Following the registration of
the Series A Conversion Shares under the Securities Act of 1933, as amended, such 2,500,000 Series A Conversion Shares shall be
issued to former employees and stockholders of an Affiliate of Vert, subject to a one year restriction on resale of such shares
of Series A Conversion Shares.

 

(e)
Conversion of the Option Shares. As set forth in the Series C Certificate of Designation, upon the consummation of the
Company IPO, the shares of Fully-Diluted Common Stock of the Company to be issued to the Option Holders shall have a minimum “Market
Value” (as defined in the Share Purchase Agreement) of not less than $16,460,000, represent not less than 20.575% of
the Fully-Diluted Common Stock of the Company and be the Company Class A Common Stock. In the event that the Subject Shares and
any additional Everest Existing Shares purchased by the Company under the Share Purchase Agreement are in excess of 82.3% of the
Existing Everest Shares, then the number of shares of Fully-Diluted Company Common Stock issued to the Option Holders and other
Everest Display shareholders shall be increased to a maximum of 25% of the Fully-Diluted Company Common Stock.

 

(f)
Closing of Acquisitions. To avoid potential adverse accounting treatment, for all purposes of the Share Purchase Agreement,
this Agreement and the transaction documents relating to the Genesis and Globisens acquisitions, the acquisition of the Subject
Shares under the Share Purchase Agreement shall be consummated on the Closing Date prior to the acquisitions of
Genesis and Globisens.

 

(g)
Fully-Diluted Common Stock. Based on (i) the Subject Shares purchased by the Company under the Share Purchase Agreement
represents 82.3% of the 33,000,000 Existing Everest Shares (as defined in the Share Purchase Agreement), and (ii) the acquisitions
of Genesis, EDI and Globisens are consummated, immediately following a Liquidity Event (but excluding shares of Company Common
Stock or warrants issued in connection with the Company IPO or other Liquidity Event), the outstanding Fully-Diluted Common Stock
of the Company would be as follows:

 

	Stockholder Group	 	Fully-Diluted Company Common Stock	 
	 	 	No. of Shares	 	 	%	 
	 	 	 	 	 	 	 	 	 
	Vert Capital Corp.	 	 	16,000,000	 	 	 	28.584	%
	Other Investors	 	 	9,600,000	 	 	 	17.150	%
	Stock Purchase Warrants	 	 	5,150,000	 	 	 	9.200	%
	Logical Choice Technologies Former Stockholders	 	 	2,500,000	 	 	 	4.466	%
	Logical Choice Corporation Employee Stock Option Pool	 	 	5,300,000	 	 	 	9.468	%
	Everest Display, Inc. Majority Stockholders Option Shares	 	 	9,986,500	 	 	 	17.841	%(*)
	Everest Display, Inc. Stock Option Pool	 	 	2,554,550	 	 	 	4.564	%
	Everest Display, Inc. Transaction Bonus Shares	 	 	798,920	 	 	 	1.427	%
	Globisens Stockholders	 	 	1,847,000	 	 	 	3.300	%
	Genesis Collaboration, LLC Former Members	 	 	2,239,000	 	 	 	4.000	%
	Fully-Diluted Common Stock	 	 	55,975,970	 	 	 	100.000	%
	Everest Display Inc. Majority Stockholders	 	 	 	 	 	 	 	 
	Additional Adjustment Shares (see Section 2.1(i) below)	 	 	1,653,000	 	 	 	 	 
	Total Fully-Diluted Common Stock, as Adjusted	 	 	57,628,970	 	 	 	 	 

 

(*)
Upon the occurrence of a Liquidity Event, the shares of Fully-Diluted Common Stock issued to the Everest Display Inc. Majority
Stockholders shall have a minimum “Market Value” (as defined in the Share Purchase Agreement) of not less than
$16,460,000, represent not less than 20.575% of the Fully-Diluted Common Stock of the Company and be the Company Class A Common
Stock. In the event that the Subject Shares and any additional Everest common shares purchased by the Company under the Share
Purchase Agreement are in excess of 82.3% of the Existing Everest Shares, then the number of shares of Fully-Diluted Company Common
Stock issued to the Option Holders and other Everest Display shareholders shall be increased to a maximum of 25% of the Fully-Diluted
Company Common Stock.

 

    	4

    	 

    

 

(h)
Transaction Bonus Shares. In addition to the Option Shares, on the Closing Date, the Company shall issue to the Option
Holders additional shares of Company Class A Common Stock representing eight (8.0%) percent of the number of the “Conversion
Shares” referred to below (the “Transaction Bonus Shares”).

 

(i)
Adjustment Shares. Based on the Company’s acquisition of 82.3% of the Existing Everest Shares, the shares of Company
Class A Common Stock issued to the Option Holders upon conversion of the Option Shares (the “Conversion Shares”)
should represent 20.575% of the Fully-Diluted Common Stock of the Company having a minimum Market Value of not less than $16,460,000
and the Transaction Bonus Shares should represent 8% of the number of the Conversion Shares, so that the total number of Conversion
Shares and Transaction Bonus Shares to be issued to the Option Holders on and immediately following the Closing Date should represent
an aggregate of 22.221% of the Fully-Diluted Common Stock. Since based on the timing of the acquisitions, the above Conversion
Shares and Transaction Bonus Shares only represent a total of 19.268% of the Fully-Diluted Common Stock, at Closing the Option
Holders shall receive upon conversion of their Option Shares additional shares of Company Class A Common Stock representing 2.953%
of the Fully-Diluted Common stock, as adjusted.  By multiplying the Closing Fully-Diluted Common Stock by a factor of 1.02953
(100.000% plus an additional 2.953%) results in an additional 1,653,000 shares of Company Class A Common Stock (the “Adjustment
Shares”).   In addition, the Option Holders are to receive stock option entitling them to purchase additional
shares of Company Class A Common Stock representing five (5%) of the Fully-Diluted Common Stock of the Company as at the Closing
Date. Accordingly, the Everest Display Stock Option Pool shall be increased by 244,249
shares of Company Class A Common Stock to represent 5.0% of the 55,975,970 shares of Fully Diluted Common Stock.

 

(j)
Issuance of Class B Common Stock. All shares of Company Common Stock to be issued upon exercise of stock options in the
Logical Choice Corporation Employee Stock Option Pool and the Everest Display Stock Option Pool shall be issued as shares of Company
Class B Common Stock. The Company Class A Common Stock and the Company Class B Common Stock shall rank equally and be identical
in all respects, except that the holders of Company Class B Common Stock shall not be entitled to vote for or consent to the election
of directors or with respect to any other matters submitted to the vote or consent of stockholders of the Company. Notwithstanding
any provision under this Agreement to the contrary, the Conversion Shares, Transaction Bonus Shares and Adjustment Shares (shall
be issued as Company Class A Common Stock by the Company and shall be entitled to vote for or consent of stockholders of the Company.
With respect to the Class B Common Stock issuable upon exercise of stock options granted in the Logical Choice Corporation Employee
Stock Option Pool and the Everest Display Stock Option Pool, such shares of Class B Common Stock (collectively, the “Option
Pool Shares”) shall, following the Company’s IPO, be registered for resale under the Securities Act on a short
Form S-8 registration statement and therefore publicly tradable on the National Securities Exchange.

 

    	5

    	 

    

 

(k)
Additional Acquisitions of Target Companies. Prior or subsequent to the Closing and a Liquidity Event, in order to enhance
shareholder value, in addition to the acquisitions of Genesis and Globisens, the Company shall use its commercially reasonable
efforts to consummate one or more acquisitions (collectively, the “Acquisitions”) of all or a
majority the capital stock or other equity of one or more corporations or limited liability companies which are not Affiliates
of the Company or Vert (each, individually, a “Target Company” and, collectively, the “Target Companies”)
and which are engaged in the Business.

 

(l)
Acquisition Securities. As used in this Agreement, the term “Acquisition Securities” shall mean and
include all Company Common Stock, convertible notes or convertible debentures of the Company, all shares of Series C Preferred
Stock issued to the Option Holders under this Option Agreement and all other shares of Acquisition Preferred Stock, if any, that
may be issued prior to or become issuable contemporaneously with the date of consummation of the Liquidity Event in connection
with the acquisition of the assets, securities or businesses of any other Person.

 

(m)
Other Adjustments.

 

(i)
In the event and to the extent that any of the Acquisitions of the Target Companies referred to above shall not occur or the Fully-Diluted
Common Stock of Parent at the time of the Liquidity Event shall be other than the estimated 55,975,970 shares of Fully-Diluted
Common Stock of Parent referred to above, the number of Automatic Conversion Shares (as defined in the Series C Certificate of
Designations) shall be appropriately adjusted to reflect the number of shares equal to the product of the Selling Parties’
Percentage and the then-outstanding number of shares of Fully-Diluted Common Stock of Parent. In addition, in the event that the
Company shall at any time on or after the Closing Date subdivide (by any stock split, stock dividend, recapitalization or otherwise)
one or more classes of its outstanding shares of Common Stock into a greater number of shares, the number of Automatic Conversion
Shares will be proportionately adjusted to reflect the number of shares equal to the product of the Selling Parties’ Percentage
and the then-outstanding number of shares of Fully-Diluted Common Stock of Parent. If the Company at any time on or after the
Closing Date combines (by combination, reverse stock split or otherwise) one or more classes of its outstanding shares of Common
Stock into a smaller number of shares, the number of Automatic Conversion Shares will be proportionately adjusted to reflect the
number of shares equal to the product of the Selling Parties’ Percentage and the then-outstanding number of shares of Fully-Diluted
Common Stock of Parent. If the Company enters into signed definitive acquisition agreements in connection with the Acquisitions
of the Target Companies, the number of Automatic Conversion Shares will be proportionately adjusted to reflect the number of shares
equal to the product of the Selling Parties’ Percentage and the sum of the number of shares of Fully-Diluted Common Stock
of Parent then-outstanding and all Acquisition Securities issuable pursuant to such signed definitive acquisition agreements.

 

    	6

    	 

    

 

(ii)
Any adjustment under this Section 2.1(m) shall become effective at the close of business on the date the subdivision
or combination becomes effective.

 

(iii)
Upon the occurrence of any adjustment under this Section 2.1(m), the Company shall notify the Option Holders in accordance with
Section 3.2 of such adjustment and provide to the Option Holders the relevant documents containing the details of such adjustment,
including, but not limited to the official stock ledger of the Company.

 

2.2
Required Consent. Notwithstanding the foregoing, or any other provision of the Share Purchase Agreement or this Option Agreement
to the contrary, the final terms and conditions of any Reverse Merger Transaction or Sale of Control Transaction proposed to be
entered into by the Company on or before the Closing Date shall be subject to the prior approval and consent of the Shareholders’
Representative.

 

2.3
Certain Definitions. As used in this Option Agreement, capitalized terms used in this Agreement, but not otherwise defined
elsewhere in this Agreement shall have the meanings given to them in the Share Purchase Agreement or the Series C Certificate
of Designations.

 

2.4
Agreements, Filings, Financial and Other Information. On or before the Closing Date, the Company shall furnish to the Option
Holders and their authorized representatives reasonable and timely access to information, financial or otherwise, necessary in
order to satisfy the requirements for the Option Holders’ legal and internal compliance obligations, including, but not
limited to (i) true and complete copies of all agreements, registration statements, financial information and other documentation
required to be executed or filed with the SEC in connection with consummating any one or more Liquidity Event, and (ii) a letter
of valuation of the Company and its Target Companies by Wellington Shields & Company or other reputable investment bankers.

 

2.5
Lock Up Agreements. In connection with any IPO (as defined in the Share Purchase Agreement) or a Reverse Merger Transaction,
if the underwriter of Company securities requests that certain existing stockholders of Company agree, for a period of time, not
to sell, transfer, hypothecate or otherwise assign (collectively, “Transfer”) a portion of the equity securities
owned by them, the Option Holders do hereby covenant and agree that they shall use their commercially reasonable efforts to cause
those persons who hold five percent or more of the Fully-Diluted Common Stock of Parent (the “Principal Shareholders”)
to execute and deliver an agreement, in form and content satisfactory to the board of directors of Company, pursuant to which,
inter alia, the Principal Shareholders or their assignees or nominees (the “Lock-up Parties”) shall
agree not to effect any Transfer (except to members of their immediate families or trusts for the benefit of such family members)
of any shares of the Fully-Diluted Common Stock of Parent or Series C Preferred Stock then owned of record or beneficially by
them for such period of time as shall be specified in such agreement (the “Lock-up Agreement”). Notwithstanding
the foregoing, the Lock-up Parties shall only be required to execute a Lock-up Agreement if (i) Vert, and the executive officers
and directors of the Company and the other shareholders of the Company are also required to execute Lock-up Agreements containing
substantially identical terms and conditions, including, but not limited to, the period of restrictions on Transfer; and (ii)
the period of restrictions on Transfer does not exceed 180 days from the date of such Lock-up Agreement.

 

2.6
Stock Options. On or before the Closing Date, the Company shall establish a stock option plan solely for the benefit of employees
of the Everest Group, pursuant to which inter alia, such individuals may be issued stock option grants of the Company
that represent on an aggregate basis five (5%) percent of the Fully-Diluted Common Stock of Parent and which vests annually in
equal installments over a four (4) year period (commencing one year after the Closing Date). The allocation of initial stock option
grants to be issued thereunder shall be determined in good faith jointly by the Company and the Shareholders’ Representative.

 

    	7

    	 

    

 

2.7
Approvals. Each of the conditions to closing in Section 6 of the Share Purchase Agreement shall have been satisfied or waived
in writing at or before the Closing Date under the terms of the Share Purchase Agreement.

 

2.8
Registration Rights. Following consummation of the IPO, in the event and to the extent that
the Company intends to file a registration statement under the Securities Act to register shares of Common Stock of the Company
for the account of any other stockholder of the Company (a “Resale Registration Statement”),
not later than thirty days prior to the filing of such Resale Registration Statement with the SEC, the Company shall give prompt
written notice to the Holders of its intention to do so. Unless waived in writing by any Holder, the Company shall offer to the
Holders to cause not less than twenty-five percent (25%) of all shares of Common Stock of the Company that are and will be included
in such Resale Registration Statement to consist of shares of Common Stock that are be held of record and beneficially by the
Holders, including those held as a result of, or issuable upon, the conversion or exercise of the Series C Preferred Stock (the
“Registrable Securities”). In such connection, the Company shall use
its best efforts to cause the Registrable Securities to be registered under the Securities Act with the other securities which
the Company at the time proposes to register to permit the sale or other disposition by the Holders of the Registrable Securities
to be so registered, including, if necessary, by filing with the Securities and Exchange Commission a post-effective amendment
or a supplement to the Resale Registration Statement filed by the Company or the prospectus related thereto. There is no limitation
on the number of such Resale Registration Statements to which the Holders are entitled to participate in pursuant to this Section
2.8; provided, that the Holders as well as all other Persons participating in such Resale Registration Statement shall provide
appropriate indemnification to the Company with respect to any disclosures made therein with respect to such Holder(s). All such
Registrable Securities shall, however, be subject to the limitations on transfer set forth in Section 11 of the Certificate of
Designations.

 

In
addition to, and not in lieu of the above, but subject at all times to the prior written approval or consent of the managing underwriter
in connection with the Company’s IPO, the Company shall use its good faith efforts to include in the registration statement
related to such IPO, (the “IPO Registration Statement”) up to 30% of the Registrable Securities owned by Holders;
provided, that (a) such Holders are not officers, directors or owners of more than 9.9% of the Registrable Securities then owned
by all Holders, and (b) all such Registrable Securities included in such IPO Registration Statement do not exceed 7.5% of the
total number of shares of Common Stock of the Company issuable upon automatic conversion of the Option Shares.

 

2.9
Change of Name. Following the execution of this Agreement but prior to the consummation of the Company IPO, the Company
will change its corporate name to Boxlight Corporation.

 

Article
III

GENERAL
PROVISIONS

 

3.1
Publicity. No publicity release or announcement concerning this Agreement, the Transaction Documents or the transactions contemplated
hereby and thereby shall be issued without advance approval of the form and substance thereof by the Parties, except as may otherwise
be required by Law (in which case the party making such release or announcement will provide concurrent or, if practicable, prior
notice to the other Parties hereto).

 

    	8

    	 

    

 

3.2
Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have
been duly given or made on (a) delivery thereof, if by hand; (b) upon receipt, if sent by mail (registered or certified mail,
postage prepaid, return receipt requested); (c) on the second Business Day following deposit, if sent by a recognized overnight
delivery service; or (d) upon transmission, if sent by facsimile transmission (in each case with receipt verified by electronic
confirmation), in each case as follows:

 

	(i)
        if to Company or Vert, to:

         

        Boxlight
        Display, Inc. and

        Logical
        Choice Corporation

        c/o
        Vert Capital Corp.

        10951
        W. Pico Blvd. STE 204

        Los
        Angeles, CA 90064

        Telephone:
        (310) 785-6600

        Facsimile
        No.: (310) 785-6616

        Attn:
        Adam Levin, CEO
	(ii)
        if to Option Holders or to Shareholders’ Representative, to:

         

        K
        Laser Technology, Inc.

        No.
        1, Li Hsin Road VI Science-Based Indurstrial Park, Hsinchu, Taiwan

        Attention:
        Alex Kuo, Chairman

        Telephone:+
        886 3 577 0316

        Facsimile No: + 886 3 563 8430

	 	 
	with
        a copy to:

         

        CKR
        Law LLP

        1330
        Avenue of the Americas,

        35th
        floor

        New
        York, NY 10019

        Attention:
        Stephen A. Weiss

        Telephone:
        (212) 400-6900

        Cell
        Phone: (917) 797-0015

        Email:
        sweiss@ckrlaw.com

         

         
	with
        copies to:

         

        Chen
        & Lin Attorney at Law

        Bank
        Tower,12th Floor, 205 Tun Hwa North Road,

        Taipei,
        Taiwan 105

        Attn:
        Grace Yu, Esq.

        Phone: 
        886-2-27150270

        Direct
        Dial: 886-2-25147510

        Email:
        graceyu@chenandlin.com

         

        White
        & Case

        3000
        El Camino Real

        5
        Palo Alto Square, 9th Floor

        Palo
        Alto, CA  94306

        Attn:
        Eric Hwang

        Phone:
        650-213-0388

        Email:
        eric.hwang@whitecase.com

 

provided,
that each party hereto shall promptly notify the other Parties hereto of any change in its contact information, which revised
contact information shall thereafter be for purposes of this Section 3.2 until further revised.

 

3.3
Entire Agreement. This Agreement (including the Exhibits and Schedules hereto) and the Transaction Documents contain the entire
agreement among the Parties with respect to the purchase of the Merger and related transactions and supersede all prior agreements,
written or oral, with respect thereto.

 

3.4
Incorporation by Reference. All of the representations and warranties of the Parties contained in the Share Purchase Agreement
and all of their respective covenants and agreement contained therein, are hereby incorporated by this reference into this Agreement,
and may be relied upon by the Party or Parties for whose benefit such representations, warranties, covenants or agreement were
given.

 

3.5
Waivers and Amendments. This Agreement may be amended, modified, superseded, cancelled, renewed or extended, and the terms
and conditions hereof may be waived, only by a written instrument signed by the Parties hereto or, in the case of a waiver, by
the party waiving compliance.  No delay on the part of any party in exercising any right, power or privilege hereunder shall
operate as a waiver thereof, nor shall any waiver on the part of any party of any right, power or privilege hereunder, nor any
single or partial exercise of any right, power or privilege hereunder, preclude any other or further exercise thereof or the exercise
of any other right, power or privilege hereunder.  The rights and remedies herein provided are cumulative and are not exclusive
of any rights or remedies which any party may otherwise have at law or in equity.

 

    	9

    	 

    

 

3.6
Exhibits and Schedules. The Exhibits and Schedules to this Agreement are a part of this Agreement as if set forth in full
herein. When a reference is made in this Agreement to an Article, Section, Exhibit or Schedule, such reference is to an Article
or Section of, or an Exhibit or Schedule to, this Agreement unless otherwise indicated.

 

3.7
Headings. The headings in this Agreement are for reference purposes only and shall not in any way affect the meaning or interpretation
of this Agreement.

 

3.8
Counterparts. This Agreement may be executed in one or more original or facsimile counterparts, and by the different Parties
hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together
shall constitute one and the same agreement.

 

3.9
Construction and Interpretation. The Parties acknowledge and agree that this Agreement has been freely negotiated and shall
be deemed to have been drafted by the Parties jointly. Accordingly, no court should construe any provision for or against any
party as a result of such party being involved in the drafting of this Agreement.

 

3.10
Assignment. No party may assign or delegate all or any portion of its rights, obligations or liabilities under this Agreement
without the prior written consent of the other Parties to this Agreement.

 

3.11
Parties in Interest. This Agreement shall be binding upon and inure solely to the benefit of each Party hereto, and, except
as otherwise expressly provided herein, nothing contained in this Agreement, express or implied, is intended to or shall confer
upon any other Person any right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

 

3.12
Severability. If any term or other provision of this Agreement is invalid, illegal, or incapable of being enforced by any
rule of law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and
effect. Upon determination that any term or other provision is invalid, illegal, or incapable of being enforced, the Parties hereto
shall negotiate in good faith to, or the court making such a determination shall, modify this Agreement so as to effect the original
intent of the Parties as closely as possible in an acceptable manner to the effect that the transactions contemplated hereby are
fulfilled to the extent possible.

 

3.13
Specific Performance. The Parties hereto agree that irreparable damage would occur in the event that any of the provisions
of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed
that the Parties shall be entitled to seek an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically
the terms and provisions hereof in any jurisdiction permitted under this Agreement, this being in addition to any other remedy
to which they are entitled at law or in equity.

 

3.14
Governing Law; Forum. This Agreement and shall be governed by the laws of the State of Delaware, United States of America.
The Parties hereto do hereby consent and submit to the venue and jurisdiction of the state or federal courts residing in the state
of Delaware as the sole and exclusive forum for such matters of disputes, and further agree that, in the event of any action or
suit as to any matters of dispute among the Parties, service of process may be made upon the other party by mailing a copy of
the summons and/or complaint to the other party at the address set forth herein. Notwithstanding anything to the contrary contained
herein, the Parties may seek equitable relief, or enforce any final judgment of any such federal or state court residing in the
state of Delaware, in any other jurisdiction in any manner provided by applicable law.

 

Balance
of page left blank – signature pages to follow

 

    	10

    	 

    

 

IN
WITNESS WHEREOF, the Parties have caused their duly authorized representatives to execute this Agreement on the date first above
written.

 

	Company:	LOGICAL
    CHOICE CORPORATION
	 	 	 
	 	By:	/s/
    Mark Elliott 
	 	Name:	Mark
    Elliott
	 	Title:	CEO
	 	 	 
	Vert:	VERT
    CAPITAL CORP
	 	 	 
	 	By:	/s/ Michael
    Pope
	 	Name:	Michael
    Pope
	 	Title:	Managing
    Director
	 	 	 
	Option
    Holders:	K
    LASER TECHNOLOGY INC.
	 	 	 
	 	By:	/s/
    Alex Kuo 
	 	Name:	Alex
    Kuo
	 	Title:	Chairman

 

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 
	 	林慶龍

	 	 	 
	 	By:	/s/
    林慶龍 
	 	 	 
	 	Name:	林慶龍

 

 

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 
	 	林秀淩
	 	 	 
	 	By:	/s/
    林秀淩 
	 	 	 
	 	Name:	林秀淩

 

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 
	 	唐逸中
	 	 	 
	 	By:	/s/
    唐逸中 
	 	 	 
	 	Name:	唐逸中

 

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 
	 	陳際榮
	 	 	 
	 	By:	/s/
    陳際榮 
	 	 	 
	 	Name:	陳際榮

 

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 
	 	呂世傑
	 	 	 
	 	By:	/s/
    呂世傑 
	 	 	 
	 	Name:	呂世傑

  

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 	 
	 	瑜得科技股份有限公司
	 	 	 
	 	(ULTMOST
    TECHNOLOGY CORP.)
	 	 	 
	 	By:
    	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 

 

 

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 	 
	 	英屬維京群島商貝斯通有限公司
	 	 	 
	 	(BEST
    TONE ASSOCIATES LTD.)
	 	 	 
	 	By:
    	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 

 

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 
	 	英屬維京群島商新界科技有限公司
	 	 
	 	(NEWEDGE
    TECHNOLOGY LTD.)
	 	 	 
	 	By:
    	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 

 

    	 

    	 

    

 

	Option
    Holders:	OTHER OPTION HOLDERS
	 	 	 
	 	瑜得電子有限公司
	 	 	 
	 	(ULTMOST ELECTRONIC LTD.)

	 	 	 
	 	By:
    	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 

 

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 
	 	香港華得電子有限公司
	 	 
	 	(CLAVIS
    LTD.) 
	 	 	 
	 	By:
    	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 

 

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 
	 	英屬維京群島商
    MW CAPITAL INC.
	 	 
	 	(MW
    CAPITAL INC.)
	 	 	 
	 	By:
    	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 

 

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 	 
	 	By:	 
	 	 	 
	 	Name:	 

 

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 
	 	李美慧
	 	 	 
	 	By:	/s/
    李美慧 
	 	 	 
	 	Name:	李美慧

 

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 
	 	吳清課
    
	 	 	 
	 	By:	/s/
    吳清課 
	 	 	 
	 	Name:	吳清課

 

    	 

    	 

    

 

	Option
    Holders:	OTHER
    OPTION HOLDERS
	 	 
	 	賴榮秀
	 	 	 
	 	By:	/s/
    賴榮秀 
	 	 	 
	 	Name:	賴榮秀

 

    	 

    	 

    

 

Exhibit
A

 

list
of Majority shareholders

 

 

 

    	 

    	 

    

 

Exhibit
B

 

series
c CErtificate of designations

 

CERTIFICATE
OF DESIGNATIONS OF THE

SERIES C CONVERTIBLE PREFERRED STOCK OF

LOGICAL CHOICE CORPORATION

 

PURSUANT
TO SECTION ___

OF THE NEVADA REVISED STATUTES

 

I,
Michael Pope, hereby certify that I am the Chief Financial Officer of Logical Choice Corporation (the “Corporation”),
a corporation organized and existing under the Nevada Revised Statutes, and further do hereby certify:

 

That
pursuant to the authority expressly conferred upon the Board of Directors of the Corporation (the “Board”)
by the Corporation’s Articles of Incorporation, as amended (the “Articles of Incorporation”), the Board
on [  ], 2015, adopted the following resolutions creating a series of preferred stock designated as Series C Convertible
Preferred Stock, none of which have been issued:

 

RESOLVED,
that the Board designates the Series C Convertible Preferred Stock and the number of shares constituting such series, and fixes
the rights, powers, preferences, privileges and restrictions relating to such series in addition to any set forth in the Articles
of Incorporation as follows:

 

TERMS
OF SERIES C CONVERTIBLE PREFERRED STOCK

 

ARTICLE
I DESIGNATION AND NUMBER.

 

1.1
A series of Preferred Stock, designated as Series C Convertible Preferred Stock (“Series C Preferred Stock”),
par value $0.0001 per share, is hereby established. The number of authorized shares of Series C Preferred Stock shall initially
be 270,000 shares (as adjusted, pursuant to Section Article IV, the “Authorized Shares”), and the stated value amount
per share of Series C Preferred Stock shall be $26.98 (the “Stated Value Per Share”). 

 

1.2
Pursuant to the Share Purchase Agreement, the Company acquired a minimum of 82.3% of the issued and outstanding common shares
of Everest Display, Inc. and may acquire additional common shares of Everest Display, Inc.

 

1.3
The Series C Preferred Stock is being issued pursuant to the terms of the Everest Option Agreement. 

 

1.4
As used in this Certificate, the term “Automatic Conversion Shares” shall mean the aggregate number of shares
of Company Class A Common Stock issuable upon the automatic conversion of all of the Series C Preferred Stock into such Common
Stock upon the occurrence of a Liquidity Event; being that number of shares of Common Stock resulting from (a) multiplying the
final percentage of the issued and outstanding common shares of Everest Display, Inc. acquired by the Company by Twenty Million
($20,000,000) Dollars, and (b) dividing the product thereof by the Per Share Price; provided,
that, the Automatic Conversion Shares shall represent not less than 20.575% and not
more than 25.00% of the Fully-Diluted Common Stock of the Corporation.

 

1.5
As used in this Certificate, the term “Everest Option Agreement” shall mean the option agreement, dated as
of [  ], 2015
among the Corporation, K Laser Technology, Inc. and other parties thereto.

 

    	 

    	 

    

 

1.6
As used in this Certificate, the term “Fully-Diluted Common Stock” shall have the same meaning as the definition
of “Fully-Diluted Common Stock of the Parent” as set forth in the Share Purchase Agreement.

 

1.7
As used in this Certificate, the term “Holder” shall mean one or more holder(s) of shares of Series C Preferred
Stock.

 

1.8
As used in this Certificate, the term “Majority Holders” shall mean those persons who were issued a majority
of the shares of Series C Preferred Stock pursuant to the terms of the Everest Option Agreement to the extent that such persons
continue to own capital stock in the Corporation.

 

1.9
As used in this Certificate, the term “Share Purchase Agreement” shall mean the share purchase agreement dated
as of [  ], 2015
among K Laser Technology, Inc., Boxlight Display, Inc., and the other Majority Shareholders
(as defined in the Share Purchase Agreement), the Corporation and Vert Capital Corp.

 

1.10
As used in this Certificate, the term “Liquidity Event” shall have the meaning as such term is defined in the
Share Purchase Agreement.

 

1.11
As used in this Certificate, the term “Market Value” shall have the meaning as such term is defined in the
Share Purchase Agreement.

 

1.12
As used in this Certificate, the term “Per Share Price” shall have the meaning as such term is defined in the
Share Purchase Agreement.

 

1.13
As used in this Certificate, the term “IPO” shall have the meaning as such term is defined in the Share Purchase
Agreement.

 

1.14
The term “Company” as used in the Share Purchase Agreement and in the Option Agreement shall mean the Corporation.

 

ARTICLE
II RANK.
All shares of the Series C Preferred Stock shall rank senior to (i) to the Corporation’s Common Stock, $0.0001 par
value per share, of the Corporation (the “Common Stock”) and any other class of securities which is specifically
designated as junior to the Series C Preferred Stock (collectively, with the Common Stock, the “Junior Securities”);
and (ii) pari passu with any other class or series of Preferred Stock of the Corporation hereafter created specifically
ranking, by its terms, on parity with the Series C Preferred Stock, including without limitation, 2,500,000 shares of Series A
Preferred Stock, $1.00 stated value per share, 1,000,000 shares of Series B Preferred Stock, $1.00 stated value per share and
all other shares of Preferred Stock of the Corporation (other than the Series C Preferred Stock) to be issued in series in connection
with the “Acquisitions” of the “Target Companies,” as those terms are defined in the Everest Option Agreement,
and to any notes, convertible securities or class or series of capital stock of the Corporation (including Preferred Stock) hereafter
issued for the purpose of consummating any public or private financing (collectively, the “Pari Passu Securities”),
in each case as to distribution of assets upon liquidation, dissolution or winding up of the Corporation, whether voluntary or
involuntary. 

 

ARTICLE
III DIVIDENDS.

 

(a)
The Holders shall be entitled to receive if, at the times set forth in this Section 0, cumulative annual dividends per share
equal to six percent (6%) of the aggregate Liquidation Preference (hereinafter defined) of the issued and outstanding Series C
Preferred Stock. Accrual of such dividends shall be computed on a 365-day basis, and shall be payable in full when the Series
C Preferred Stock is redeemed by the Corporation in the manner provided in paragraph (Article II) below. Such dividends shall
be payable annually each anniversary of the issue date of the Series C Preferred Stock in additional shares of Series C Preferred
Stock, and such dividends shall accrue whether or not declared and regardless of whether there are profits, surplus or
other funds legally available for payment of dividends, and shall be earned or payable from and after the issue date of the Series
C Preferred Stock. All dividends paid with respect to shares of Series C Preferred Stock pursuant to this Section 0 shall
be paid pro rata to the Holders entitled thereto. Dividends on the Series C Preferred Stock may not be declared, paid or set apart
for payment, nor may the Corporation redeem, purchase or otherwise acquire any shares of Series C Preferred Stock, if the Corporation
is not solvent or would be rendered insolvent thereby.

 

    	 

    	 

    

 

(b)
Except as otherwise set forth in this Section 0, the Series C Preferred Stock shall not pay a fixed or other dividend. The
Holders shall, however, be entitled to receive dividends when, as, and if declared by the Board, in an amount which shall be paid
pro rata on the Common Stock and the Series C Preferred Stock, on an equal priority, pari passu basis, according to the
number of shares of Common Stock held by the stockholders, where each Holder is to be treated for this purpose as holding (in
lieu of such shares of Series C Preferred Stock) the greatest whole number of shares of Common Stock then issuable upon conversion
in full of such shares of Series C Preferred Stock. The right to such dividends on shares of Series C Preferred Stock shall not
be cumulative, and no right shall accrue to Holders by reason of the fact that dividends on said shares are not declared in any
period, nor shall any undeclared or unpaid dividend bear or accrue interest.

 

ARTICLE
II LIQUIDATION PREFERENCE. In the event of a merger, sale (of substantially all assets
or stock), any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation, then, either
(i) simultaneous with any distribution or payment on Pari Passu Securities, and (ii) before any distribution or payment shall
be made to the holders of the Common Stock or any other Junior Securities, each Holder of Series C Preferred Stock then outstanding
shall be entitled to be paid, out of the assets of the Corporation available for distribution to its stockholders, an amount (the
“Liquidation Preference”) equal to (i) the product of (A) the aggregate number of shares of Series C Preferred
Stock then outstanding, (B) the Stated Value Per Share and (C) a multiple of 3.71 plus (ii) any accrued but unpaid dividends.
If the assets of the Corporation are not sufficient to generate cash sufficient to pay in full the Liquidation Preference, then
the Holders of Series C Preferred Stock shall share ratably (together with holders of any Pari Passu Securities) in any distribution
of cash generated by such assets in accordance with the respective amounts that would have been payable in such distribution as
if the amounts to which the Holders of outstanding shares of Series C Preferred Stock are entitled were paid in full.

 

ARTICLE
III VOTING RIGHTS. Each share of Series C Preferred Stock
shall have a number of votes equal to the number of shares of Common Stock then issuable upon conversion of each share of Series
C Preferred Stock. Except as otherwise set forth herein, the Holders shall have no right to vote as a separate class on any matter
submitted to vote by the stockholders of the Corporation, excluding, however, any proposed amendment that would alter any right
given to the Series C Preferred Stock; in which event the Series C Preferred Stock may vote as a separate class with respect to
such amendment. Holders shall be entitled to notice of any stockholders’ meeting in accordance with the Bylaws of the Corporation
and shall vote with holders of the Common Stock upon the election of directors and upon any other matter submitted to a vote of
stockholders. Fractional votes by the Holders shall not, however, be permitted and any fractional voting rights resulting from
the above formula (after aggregating all shares into which shares of Series C Preferred Stock held by each Holder could be converted)
shall be rounded to the nearest whole number (with one-half being rounded upward).

 

    	 

    	 

    

 

ARTICLE
IV CONVERSION.

 

4.1
Conversion Ratio. Each full share of Series C Preferred Stock
shall be convertible into Company Class A Common Stock of the Corporation, at any time, into that number of shares of Company
Class A Common Stock at a conversion ratio per share of Series C Preferred Stock as shall be determined by dividing (A) the number
of Authorized Shares, by (B) that number of shares of Common Stock equal to the number of Automatic Conversion Shares (the “Series
C Conversion Ratio”). Accordingly the initial conversion ratio (the “Conversion Ratio”), shall be determined
by dividing one share of the Series C Preferred Stock by the Series C Conversion Ratio; provided,
that, depending upon the final percentage of the “Existing
Everest Shares” (as defined in the Share Purchase Agreement) that is acquired by the Corporation the number of Conversion
Shares (defined below) and the Series C Conversion Ratio shall result in all of the Conversion Shares having a Market Value of
not less than Sixteen Million Four Hundred and Sixty Thousand ($16,460,000 Dollars, and shall result in all of the Conversion
Shares representing not less than 20.575% of the Fully-Diluted Company Common Stock and not more than 25.0% of the Fully-Diluted
Company Common Stock.

 

For
the avoidance of doubt, in the event and to the extent that the Automatic Conversion Shares shall represent less than 20.575%
of the Fully-Diluted Common Stock (subject to increase, as provided above, if the Corporation acquires in excess of 82.3% of the
Existing Everest Shares under the Share Purchase Agreement), upon the optional or automatic conversion of the Series C Preferred
Stock, the Holders of Series C Preferred Stock shall be entitled to receive, in addition to such Automatic Conversion Shares,
the “Adjustment Shares” as defined in the Everest Option Agreement. In addition, if the product of multiplying
the Per Share Price by the number of Automatic Conversion Shares shall result in a Market Value of less than $16,460,000 (subject
to increase as provided above), the number of Automatic Conversion Shares shall similarly be subject to increase by the issuance
of additional shares of Common Stock.

 

4.2
Optional Conversion. The Holders of shares of Series
C Preferred Stock may, at their option and at any time or from time to time, convert all or any portion of their shares of Series
C Preferred Stock into Common Stock of the Corporation at any time or from time to time (an “Optional Conversion”).
In order to effect an Optional Conversion, a Holder of shares of Series C Preferred Stock shall: (i) fax (or otherwise deliver)
a copy of the fully executed Notice of Conversion to the Corporation (Attention: Secretary) and (ii) surrender or cause to be
surrendered the original certificates representing the Series C Preferred Stock being converted (the “Series C Preferred
Stock Certificates”), duly endorsed, along with a copy of the Notice of Conversion as soon as practicable thereafter
to the Corporation. Upon receipt by the Corporation of a facsimile copy of a Notice of Conversion from a Holder, the Corporation
shall promptly send, via facsimile, a confirmation to such Holder stating that the Notice of Conversion has been received, the
date upon which the Corporation expects to deliver the Common Stock issuable upon such conversion and the name and telephone number
of a contact person at the Corporation regarding the conversion. The Corporation shall not be obligated to issue shares of Common
Stock upon a conversion unless either the Series C Preferred Stock Certificates are delivered to the Corporation as provided above,
or the Holder notifies the Corporation that such Series C Preferred Stock Certificates have been lost, stolen or destroyed and
delivers the documentation to the Corporation.

 

4.3
Automatic Conversion. Notwithstanding anything to the contrary contained herein,
express or implied, but subject at all times to the adjustment provisions of Section 6.4 below, immediately following the occurrence
of (i) a Liquidity Event and (ii) the exercise of the Option (as defined in the Option Agreement), all, and not less than all,
of the then issued and outstanding shares of Series C Preferred Stock shall automatically, and without any further action on the
part of the Corporation or the Holder, be converted (an “Automatic Conversion”) into that number of Automatic Conversion
Shares having an aggregate Market Value of not less than $16,640,000, less the aggregate number of shares of Common Stock
previously issued in connection with any one or more Optional Conversions contemplated by Section 4.2 above. Each Holder
of Series C Preferred Stock shall be entitled to receive his, her or its pro-rata portion of the Automatic Conversion Shares determined
by the amount by which the number of shares of Common Stock into which all of such Holder’s shares of Series C Preferred
Stock may be converted pursuant to the Conversion Ratio, bears to the total number of Automatic Conversion Shares. 

 

    	 

    	 

    

 

Adjustment
for Reclassification, Exchange, and Substitution. If at any
time or from time to time after the date upon which the first share of Series C Preferred Stock was issued by the Corporation
(the “Original Issue Date”), the shares of Company Class A Common Stock issuable upon the conversion of the
Series C Preferred Stock shall be changed into the same or a different number of shares of any class or classes of stock, whether
by recapitalization, reclassification, reorganization, merger, exchange, consolidation, sale of assets or otherwise, then, in
any such event, Holders shall have the right thereafter to convert such stock into the kind and amount of stock and other securities
and property receivable upon such recapitalization, reclassification, reorganization, merger, exchange, consolidation, sale of
assets or other change by a holder of the number of shares of Company Class A Common Stock into which such shares of Series C
Preferred Stock could have been converted immediately prior to such recapitalization, reclassification, reorganization, merger,
exchange, consolidation, sale of assets or other change, or with respect to such other securities or property by the terms thereof.

 

4.5
Adjustment Upon Common Stock Event.
In the event that a Common Stock Event occurs at any time or from time to time after the Original Issue Date, the aggregate number
of shares of Common Stock into which the Series C Preferred Stock may be converted (the “Conversion Shares”)
in effect immediately prior to such event shall, simultaneously with the occurrence of such Common Stock Event, shall be proportionately
decreased or increased, as appropriate. The Conversion Shares shall be readjusted in the same manner upon the happening of each
subsequent Common Stock Event. As used herein, the term “Common Stock Event” shall mean: (a) the declaration
or payment of any dividend or other distribution on the Common Stock, without consideration, payable to one or more stockholders
in additional shares of Company Class A Common Stock or other securities or rights convertible into, or entitling the holder thereof
to receive, directly or indirectly, additional shares of Common Stock; (b) a subdivision (by stock split, reclassification or
otherwise) of the outstanding shares of Common Stock into a greater number of shares of Common Stock; or (c) a combination or
consolidation (by reverse stock split) of the outstanding shares of Common Stock into a smaller number of shares of Common Stock.

 

4.6
Adjustment of Series C Conversion Price Upon Issuance of Additional
Shares of Common Stock. In the event the Corporation shall,
at any time after the Original Issue Date and prior to a Liquidity Event, issue additional shares of Company Class A Common Stock
or Preferred Stock that is convertible into shares of Common Stock, then the Series C Conversion Price and the Conversion Ratio
shall be adjusted concurrently with such issue, so that the Series C Preferred Stock shall continue to represent not less than
twenty percent (20%) of the Fully-Diluted Common Stock of Company.

 

4.8
Reservation of Stock Issuable Upon Conversion.
The Corporation shall at all times reserve and keep available out of its authorized but unissued shares of Company Class A Common
Stock, solely for the purpose of effecting the conversion of the shares of the Series C Preferred Stock such number of its shares
of Company Class A Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding shares of
the Series C Preferred Stock; and if at any time the number of authorized but unissued shares of Company Class A Common Stock
shall not be sufficient to effect the conversion of all then outstanding shares of the Series C Preferred Stock, the Corporation
will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares
of Company Class A Common Stock to such number of shares as shall be sufficient for such purpose, including, without limitation,
engaging in best efforts to obtain the requisite stockholder approval of any necessary amendment to the Corporation’s Articles
of Incorporation.

 

    	 

    	 

    

 

4.9
Fractional Shares.
No fractional share shall be issued upon the conversion of any share or shares of Series C Preferred Stock. All shares of Common
Stock (including fractions thereof) issuable upon conversion of more than one share of Series C Preferred Stock by a Holder thereof
shall be aggregated for purposes of determining whether the conversion would result in the issuance of any fractional share.

 

ARTICLE
V NO REISSUANCE OF SERIES C PREFERRED STOCK. No share or shares of Series C Preferred Stock acquired by the
Corporation by reason of redemption, purchase, conversion or otherwise shall be reissued, and all such shares shall be canceled,
retired and eliminated from the shares which the Corporation shall be authorized to issue.

 

ARTICLE
VI REDEMPTION.  The Series C Preferred Stock is not redeemable.

 

ARTICLE
VII NOTICE. Except as may otherwise be provided for herein, all notices referred
to herein shall be in writing, and all notices hereunder shall be deemed to have been given upon the earlier of receipt of such
notice or four business days after the mailing of such notice, if sent by registered mail, with postage pre-paid, addressed: (1)
if to the Corporation, to the attention of its corporate secretary or to an agent of the Corporation designated as permitted by
the Corporation’s Articles of Incorporation, as amended; (2) if to any Holder, to such Holder at the address of such Holder
as listed in the stock record books of the Corporation (which may include the records of the Corporation’s transfer agent);
or (3) to such other address as the Corporation or Holder, as the case may be, shall have designated by notice similarly given.

 

ARTICLE
VIII AMENDMENT. This Certificate of Designation or any
provision hereof may be amended by obtaining the affirmative vote at a meeting duly called for such purpose, or written consent
without a meeting in accordance with the Nevada Revised Statutes, of (i) a majority of the outstanding Series C Preferred Stock,
voting separate as a single class, and (ii) with such other stockholder approval, if any, as may then be required pursuant to
the Nevada Revised Statutes and the Articles of Incorporation.

 

ARTICLE
IX LIMITATION ON TRANSFER.

 

9.1
The, sale, offer to sell, contract to sell, assignment, pledge, hypothecation, encumbrance
or other transfer (collectively, “Transfer”), directly or indirect, by any Holder or holder of the Conversion Shares
issuable upon conversion of such shares of Series C Preferred Stock, including (i) the use of the any shares of Series C Preferred
Stock or Conversion Shares (collectively, “Capital Stock”) as collateral for any borrowing, or (ii) the granting of
purchase options to any other person or entity, shall be prohibited until 180 days from the date of this Certificate of Designation;
provided, however, that a Transfer by a holder of Capital Stock (a “Capital Stock Holder”), (certified by such
Capital Stock Holder to the Corporation that such Transfer is for estate planning purposes), to (A) an immediate family member
(child, sibling, spouse or Company); (B) a trust, corporation, partnership, limited partnership or limited liability Corporation
that is an “affiliate” (at that term is defined in Rule 405 promulgated under the Securities Act of 1933, as amended)
of such Capital Stock Holder; or (C) in the case of a Capital Stock Holder that is an entity, stockholders, members, partners
or other equity holders of such Capital Stock Holder shall be permitted. To the extent of any permitted Transfer, the transferee
of such transferred Capital Stock shall acquire the same subject to the provisions set forth herein. 

 

9.2
In the event of any stock dividend, stock split, recapitalization, or other change affecting
the Corporation’s outstanding Common Stock effected without receipt of consideration, then any new, substituted, or additional
securities distributed to a Holder with respect to Capital Stock shall be immediately subject to the provisions of this Section Article
IX, to the same extent the Capital Stock is at such time covered by such provisions.

 

    	 

    	 

    

 

9.3
In addition to any restrictive legend required under Rule 144, the certificate for each
share of Series C Preferred Stock and Conversion Shares shall contain the following legend: 

 

“Except
in limited circumstances, the sale, offer to sell, contract to sell, assignment, pledge, hypothecation, encumbrance or other transfer
(collectively, “Transfer”) of the shares represented by this certificate are restricted in accordance with
the provisions of the Certificate of Designations of the Series C Preferred Stock, dated January __, 2015, a copy of which is
available at the offices of the Corporation.”

 

9.4
Any purported Transfer of any of the Capital Stock that is not in accordance with this Section
Article IX shall be null and void, and shall not operate to transfer any right, title or interest in such Capital Stock to the
purported transferee. Each Holder of Capital Stock agrees that the Corporation shall be entitled to prohibit the Transfer of any
Capital Stock to be made on its books unless the Transfer is permitted hereunder and has been made in accordance herewith. 

 

ARTICLE
X PROTECTIVE PROVISIONS.

 

So
long as any shares of Series C Preferred Stock are outstanding, the Corporation shall not, nor shall it permit any of its subsidiaries
to, take or agree to take any of the following corporate actions (whether by merger, consolidation or otherwise) without first
obtaining the approval (by vote or written consent) of the Holders of a majority of the issued and outstanding Series C Preferred
Stock (the “Series C Majority Holders”):

 

10.1
alter or change the rights, preferences or privileges of the Series C Preferred Stock, or
increase the authorized number of shares of Series C Preferred Stock in excess of 270,000 Shares; or

 

10.2
issue any shares of Series C Preferred Stock to Persons, other than to Option Holders pursuant
to the Option Agreement; or create or authorize the creation of or issue any shares of Preferred Stock or any other security convertible
or exercisable for any equity security having rights, preferences or privileges senior to or on parity with the Series C Preferred
Stock.

 

ARTICLE
XI CO-SALE RIGHTS.

 

11.1
If a Holder proposes to sell any shares of its Series C Preferred Stock (the “Selling
Holder”) then the Selling Holder shall promptly give written notice (the “Notice”) to each of the other Holders
at least 30 days prior to the closing of such sale. The Notice shall describe in reasonable detail the proposed sale including,
without limitation, the number of shares of Series C Preferred Stock to be transferred, the nature of such sale, the consideration
to be paid, and the name and address of each prospective purchaser or transferee.

 

    	 

    	 

    

 

11.2
Each other Holder (the “Participating Holder”) shall have the right, exercisable
upon written notice to such Selling Holder within 15 days of the Notice, to participate in such sale of Series C Preferred Stock
on the same terms and conditions. Such notice shall indicate the number of shares of Series C Preferred Stock such Participating
Holder wishes to sell.

 

(a)
Each Participating Holder shall effect its participation in the sale by promptly delivering to such Selling Holder for transfer
to the prospective purchaser one or more certificates, properly endorsed for transfer, which represent the number of shares of
Series C Preferred Stock which such Participating Holder elects to sell.

 

(b)
The stock certificate or certificates that the Participating Holder delivers to such Selling Holder shall be transferred to the
prospective purchaser in consummation of the sale of the Series C Preferred Stock pursuant to the terms and conditions specified
in the Notice, and the Selling Holder shall concurrently therewith remit to such Participating Holder that portion of the sale
proceeds to which such Participating Holder is entitled by reason of its participation in such sale. To the extent that any prospective
purchaser or purchasers prohibits such assignment or otherwise refuses to purchase shares or other securities from a Participating
Holder exercising its rights of co-sale hereunder, such Selling Holder shall not sell to such prospective purchaser or purchasers
any Series C Preferred Stock held by Selling Holder unless and until, simultaneously with such sale, such Selling Holder shall
purchase such shares or other securities from such Participating Holder on the same terms and conditions specified in the Notice.

 

(c)
To the extent that the Participating Holders do not elect to participate in the sale of the Series C Preferred Stock held by such
Selling Holder subject to the Notice, such Selling Holder may enter into an agreement providing for the closing of the sale of
such Series C Preferred Stock within thirty (30) days of such agreement on terms and conditions not materially more favorable
to the transferor than those described in the Notice. Any proposed sale on terms and conditions materially more favorable than
those described in the Notice, as well as any subsequent proposed sale of any of the Series C Preferred Stock by a Selling Holder,
shall again be subject to the co-sale rights of the Participating Holders and shall require compliance by a Selling Holder with
the procedures described in this Section 13.

 

ARTICLE
XII MISCELLANEOUS.

 

12.1
Cancellation of Series C Preferred Stock.
If any shares of Series C Preferred Stock are converted pursuant to this Certificate of Designations, the shares so converted
or redeemed shall be canceled, shall return to the status of authorized, but unissued Series C Preferred Stock of no designated
series, and shall not be issuable by the Corporation as Series C Preferred Stock.

 

12.2
Lost or Stolen Certificates.
Upon receipt by the Corporation of (i) evidence of the lost, theft, destruction or mutilation of any Series C Preferred Stock
Certificate(s) and (ii) (y) in the case of loss, theft or destruction, indemnity (without any bond or other security) reasonably
satisfactory to the Corporation, or (z) in the case of mutilation, the Series C Preferred Stock Certificate(s) (surrendered for
cancellation), the Corporation shall execute and deliver new Series C Preferred Stock Certificate(s) of like tenor and date. However,
the Corporation shall not be obligated to reissue such lost, stolen, destroyed or mutilated Series C Preferred Stock Certificate(s)
if the Holder contemporaneously requests the Corporation to convert such Series C Preferred Stock.

 

    	 

    	 

    

 

12.3
Waiver.
Notwithstanding any provision in these Certificate of Designations to the contrary, any provision contained herein and any right
of the Holders of Series C Preferred Stock granted hereunder may be waived as to all shares of Series C Preferred Stock (and the
Holders thereof) upon the written consent of the Series C Majority Holders, unless a higher percentage is required by applicable
law, in which case the written consent of the Holders of not less than such higher percentage of shares of Series C Preferred
Stock shall be required.

 

12.4
Information Rights.
So long as shares of Series C Preferred Stock are outstanding, the Corporation will deliver to each Holder of Series C Preferred
Stock (i) unaudited annual financial statements to the Holders of Series C Preferred Stock within 90 days after the end of each
fiscal year; (ii) and unaudited quarterly financial statements within 45 days of the end of each fiscal quarter. Notwithstanding
the foregoing in the event and to the extent that such information is electronically available on the web site of the Securities
and Exchange Commission (www.sec.gov), the Corporation need not separately furnish such documents to Holders of the Series
C Preferred Stock.

 

Balance
of this page intentionally left blank – signature page follows

 

    	 

    	 

    

 

The
undersigned declares under penalty of perjury under the laws of the State of Nevada that the matters set forth in this certificate
are true and correct of his own knowledge.

 

The
undersigned has executed this certificate on [  ], 2015.

 

	 	LOGICAL CHOICE CORPORATION 
	 	 	 
	 	By:	 
	 	Name:	Mark
    Elliott
	 	Title:	Chief
    Executive Officer

  

    	 

    	 

    

 

Exhibit
C

 

SECOND
AMENDED AND RESTATED ARTICLES OF INCORPORATION

 

Of

 

LOGICAL
CHOICE CORPORATION

 

The
Articles of Incorporation of LOGICAL CHOICE CORPORATION (the “Corporation”) was filed in the Office of the Secretary
of State of the State of Nevada, 202 North Carson Street, Carson City, Nevada 89701, on September 18, 2014, as document no. 20140673158-67
and entity no. E0482222014-8, and was amended and restated on September 24, 2014 as Document Number 20140682180-22.

 

The
Board of Directors of the Corporation on January 19, 2015, have unanimously adopted a resolution proposing and declaring advisable
that the Articles of Incorporation be amended and restated in its entirety pursuant to Section 78.403 of the Nevada Revised Statutes
of the State of Nevada (the “NRS”) and have duly adopted this Amended and Restated Articles of Incorporation.

 

In
lieu of a special meeting of the stockholders of the Corporation, Vert Capital Corp., the majority stockholder of the Corporation,
provided its written consent in favor of this Amended and Restated Articles of Incorporation in accordance with the provisions
of NRS Sections 78.310 and 78.390.

 

The
text of the Articles of Incorporation, as amended and restated herein, shall read as follows:

 

First:
The name of the Corporation is “Boxlight Corporation.”

 

Second:
The address of the Corporation’s registered office in the
State of Nevada is 311 South Division Street, in the city of Carson City, Nevada 89703. The name of its registered agent at such
address is The Corporation Trust Company of Nevada.

 

Third:
The nature or purpose of the business to be conducted or promoted
by the Corporation is to engage in any lawful act or activity for which corporations may be organized under the NRS.

 

Fourth:
The total number of shares of stock which the Corporation shall
have authority to issue is Two Hundred Fifty Million (250,000,000) shares, each having a par value of $0.0001 per share, consisting
of:

 

(i) One
Hundred and Fifty Hundred Million (150,000,000) shares of Class A voting Common Stock, par value $0.0001 per share (the “Class
A Common Stock”);

 

(ii) Fifty
Million (50,000,000) shares of Class B non-voting common stock, par value $0.0001 per share (the “Class B Common Stock”)
and

 

(iii) Fifty
Million (50,000,000) shares of Serial Preferred Stock, par value $0.0001 per share (the “Preferred Stock”), to be
designated at a future date.

 

    	 

    	 

    

 

The
Class A Common Stock and the Class B Common Stock are herein sometimes collectively referred to as the “Common Stock”).

 

A
statement of the powers, designations, preferences, and relative participating, optional or other special rights and the qualifications,
limitations and restrictions of the Common Stock and the Preferred Stock is as follows:

 

1. Common
Stock.

 

(a) Dividends.
Subject to the express terms of any outstanding series of Preferred Stock, dividends may be paid in cash or otherwise with respect
to the Common Stock out of the assets of the Corporation legally available therefor, upon the terms, and subject to the limitations,
as the Board of Directors of the Corporation (the “Board of Directors”) may determine. Except for the voting rights
referred to below, all shares of Common Stock of the Corporation shall be of equal rank and shall be identical in all respects.

 

(b) Liquidation
Rights. Subject to the express terms of any outstanding Preferred Stock, in the event of a Liquidation of the Corporation,
the holders of Common Stock shall be entitled to share in the distribution of any remaining assets available for distribution
to the holders of Common Stock ratably in proportion to the total number of shares of Common Stock then issued and outstanding.

 

(c) Voting
Rights. The holders of Class A Common Stock shall be entitled to one vote per share in voting or consenting to the election
of directors and for all other corporate purposes to the extent authorized by this Articles of Incorporation or the NRS. The Class
B Common Stock shall have no voting rights and holders of Class B Common Stock shall not be entitled to vote or consent to the
election of directors or with respect to any other matter submitted to the vote of the stockholders of the Corporation.

 

2. Serial
Preferred Stock. Subject to approval by holders of shares of any class or series of Preferred Stock to the extent such approval
is required by its terms, the Board of Directors is hereby expressly authorized, subject to limitations prescribed by law, by
resolution or resolutions and by filing a certificate pursuant to the applicable law of the State of Nevada, to provide, out of
the unissued shares of Preferred Stock, for series of Preferred Stock, and to establish from time to time the number of shares
to be included in each such series, and to fix the designation, powers, preferences and rights of the shares of each such series
and the qualifications, limitations or restrictions thereof.

 

The
authority of the Board of Directors with respect to each series shall include, but not be limited to, determination of the following:

 

(a) The
number of shares constituting that series and the distinctive designation of that series;

 

(b) The
rate of dividend, and whether (and if so, on what terms and conditions) dividends shall be cumulative (and if so, whether unpaid
dividends shall compound or accrue) or shall be payable in preference or in any other relation to the dividends payable on any
other class or classes of stock or any other series of the Preferred Stock;

 

    	2

    	 

    

 

(c) Whether
that series shall have voting rights in addition to the voting rights provided by law and, if so, the terms and extent of such
voting rights;

 

(d) Whether
the shares must or may be redeemed and, if so, the terms and conditions of such redemption (including, without limitation, the
dates upon or after which they must or may be redeemed and the price or prices at which they must or may be redeemed, which price
or prices may be different in different circumstances or at different redemption dates);

 

(e) Whether
the shares shall be issued with the privilege of conversion or exchange and, if so, the terms and conditions of such conversion
or exchange (including without limitation the price or prices or the rate or rates of conversion or exchange or any terms for
adjustment thereof);

 

(f) The
amounts, if any, payable under the shares thereof in the event of the Liquidation of the Corporation in preference of shares of
any other class or series and whether the shares shall be entitled to participate generally in distributions in the Common Stock
under such circumstances;

 

(g) Sinking
fund provisions, if any, for the redemption or purchase of the shares (the term “sinking fund” being understood to
include any similar fund, however designated); and

 

(h) Any
other relative rights, preferences, limitations and powers of that series.

 

FIFTH:
At all meetings of stockholders, each stockholder shall be entitled to vote, in person or by proxy, the shares of voting stock
of the Corporation owned by such stockholders of record on the record date for the meeting. When a quorum is present or represented
at any meeting, the vote of the holders of a majority in interest of the stockholders present in person or by proxy at such meeting
and entitled to vote thereon shall decide any question, matter or proposal brought before such meeting unless the question is
one upon which, by express provision of law, this Articles of Incorporation or the By-laws, a different vote is required, in which
case such express provision shall govern and control the decision of such question.

 

SIXTH:

 

1. Number
of Directors. The number of directors of the Corporation shall be fixed from time to time by the vote of a majority of the
entire Board of Directors, but such number shall in no case be less than one (1). Any such determination made by the Board of
Directors shall continue in effect unless and until changed by the Board of Directors, but no such changes shall affect the term
of any directors then in office.

 

2. Term
of Office; Quorum; Vacancies. A director shall hold office until the annual meeting for the year in which his or her term
expires and until his or her successor shall be elected and shall qualify, subject, however, to prior death, resignation, retirement,
disqualification or removal from office. Subject to the By-laws, a majority of the entire Board of Directors shall constitute
a quorum for the transaction of business. Any vacancies and newly created directorships resulting from an increase in the number
of directors shall be filled by a majority of the Board of Directors then in office even though less than a quorum and shall hold
office until his successor is elected and qualified or until his earlier death, resignation, retirement, disqualification or removal
from office.

 

    	3

    	 

    

 

3. Removal.
Subject to the By-laws, any director may be removed upon the affirmative vote of the holders of a majority of the votes which
could be cast by the holders of all outstanding shares of Common Stock entitled to vote for the election of directors, voting
together as a class, given at a duly called annual or special meeting of stockholders.

 

SEVENTH: For
the management of the business and for the conduct of the affairs of the Corporation, and in further definition, limitation and
regulation of the powers of the Corporation and of its directors and of its stockholders or any class thereof, as the case may
be, it is further provided:

 

(1) The
business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors.

 

(2) The
directors shall have the power, subject to the terms and conditions of the By-laws, to make, adopt, alter, amend, change, add
to or repeal the By-laws.

 

(3) In
addition to the powers and authority hereinbefore or by statute expressly conferred upon them, the directors are hereby empowered
to exercise all such powers and do all such acts and things as may be exercised or done by the Corporation, subject, nevertheless,
to the provisions of the NRS, this Articles of Incorporation, and any By-laws adopted by the stockholders; provided, however,
that no By-laws hereafter adopted by the stockholders shall invalidate any prior act of the directors which would have been valid
if such By-laws had not been adopted.

 

EIGHTH:

 

1. Stockholder
Meetings; Keeping of Books and Records. Meetings of stockholders may be held within or outside the State of Nevada as the
By-laws may provide. The books of the Corporation may be kept (subject to any provision contained in the NRS) outside the State
of Nevada at such place or places as may be designated from time to time by the Board of Directors or in the By-laws of the Corporation.

 

2. Special
Stockholders Meetings. Special meetings of the Stockholders, for any purpose or purposes, unless otherwise prescribed by law,
may be called by the President or the Chairman of the Board, if one is elected, and shall be called by the Secretary at the direction
of a majority of the Board of Directors, or at the request in writing of Stockholders owning a majority in amount of the Common
Stock of the Corporation issued and outstanding and entitled to vote.

 

3. No
Written Ballot. Elections of directors need not be by written ballot unless the By-laws of the Corporation shall so provide.

 

    	4

    	 

    

 

NINTH:

 

1. Limits
on Director Liability. Directors of the Corporation shall have no personal liability to the Corporation or its stockholders
for monetary damages for breach of a fiduciary duty as a director; provided that nothing contained in this Article NINTH
shall eliminate or limit the liability of a director (i) for any breach of a director’s duty of loyalty to the Corporation
or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or knowing violations
of law, or as otherwise expressly provided in the NRS, or (iii) for any transaction from which a director derived an improper
personal benefit. If the NRS is amended to authorize corporate action further eliminating or limiting the personal liability of
directors, then by virtue of this Article NINTH the liability of a director of the Corporation shall be eliminated or limited
to the fullest extent permitted by the NRS, as so amended.

 

2. Indemnification.

 

(1) The
Corporation shall indemnify, in accordance with the By-laws of the Corporation and to the fullest extent permitted from time to
time by the NRS or any other applicable laws as presently or hereafter in effect, any person who was or is a party or is threatened
to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative
or investigative, including, without limitation, an action by or in the right of the Corporation, by reason of his acting as a
director or officer of the Corporation or any of its subsidiaries (and the Corporation, in the discretion of the Board of Directors,
may so indemnify a person by reason of the fact that he is or was an employee or agent of the Corporation or any of its subsidiaries
or is or was serving at the request of the Corporation in any other capacity for or on behalf of the Corporation) against any
liability or expense actually and reasonably incurred by such person in respect thereof; provided, however, the
Corporation shall be required to indemnify an officer or director in connection with an action, suit or proceeding (or part thereof)
initiated by such person only if (i) such action, suit or proceeding (or part thereof) was authorized by the Board of Directors
and (ii) the indemnification does not relate to any liability arising under Section 16(b) of the Exchange Act, as amended, or
any rules or regulations promulgated thereunder. Such indemnification is not exclusive of any other right to indemnification provided
by law or otherwise. The right to indemnification conferred by this paragraph 2 shall be deemed to be a contract between the Corporation
and each person referred to herein.

 

(2) If
a claim under paragraph 2(1) is not paid in full by the Corporation, the claimant may at any time thereafter bring suit against
the Corporation to recover the unpaid amount of the claim and, if successful in whole or in part, the claimant shall be entitled
to be paid also the expense of prosecuting such claim. It shall be a defense to any such action (other than an action brought
to enforce a claim for expenses incurred in defending any proceeding in advance of its final disposition where any undertaking
required by the By-laws of the Corporation has been tendered to the Corporation) that the claimant has not met the standards of
conduct which make it permissible under the NRS and paragraph 2(1) for the Corporation to indemnify the claimant for the amount
claimed, but the burden of proving such defense shall be on the Corporation. Neither the failure of the Corporation (including
its Board of Directors, legal counsel, or its stockholders) to have made a determination prior to the commencement of such action
that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard of conduct
set forth in the NRS, nor an actual determination by the Corporation (including its Board of Directors, legal counsel, or its
stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a
presumption that the claimant has not met the applicable standard of conduct.

 

    	5

    	 

    

 

(3) Indemnification
shall include payment by the Corporation of expenses in defending an action or proceeding in advance of the final disposition
of such action or proceeding upon receipt of an undertaking by the person indemnified to repay such payment if it is ultimately
determined that such person is not entitled to indemnification under this Article NINTH, which undertaking may be accepted without
reference to the financial ability of such person to make such repayment.

 

(4) With
respect to any derivative action or other action against the Corporation or any of its directors, officers, underwriters, accountants,
financial advisors, or attorneys, in which wrongdoing is alleged for which the Corporation could be liable or with respect to
which the Corporation might have an indemnification obligation, no stockholder or former stockholder shall agree to pay, the Corporation
shall have no authority to pay to any plaintiff’s counsel, and no plaintiff’s counsel shall seek any legal fee, except
a fee determined for actual time expended, charged at reasonable rates not exceeding those prevailing for ordinary commercial
litigation, as agreed between the Corporation and plaintiff’s counsel before commencement of the action, subject to customary
periodic rate increases, of which plaintiff’s counsel shall advise the Corporation in advance of any such increase. Plaintiff’s
counsel shall provide the Corporation, at least monthly, a report of the time expended each day by each of its professionals in
connection with the action during the period reported upon, describing the activities in reasonable detail and the dollar amount
chargeable in connection therewith, summaries of time and charges with respect to each professional for such period and since
inception, and of out-of-pocket expenses incurred during such period and since inception. This provision cannot be amended except
by affirmative vote of holders of more than 80% of the Corporation’s outstanding shares.

 

3. Insurance.
The Corporation shall have the power (but not the obligation) to purchase and maintain insurance on behalf of any person who is
or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a
director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any
expense, liability or loss incurred by such person in any such capacity or arising out of his status as such, whether or not the
Corporation would have the power to indemnify him against such liability under this ARTICLE NINTH or the NRS.

 

4. Other
Rights. The rights and authority conferred in this ARTICLE NINTH shall not be exclusive of any other right which any person
may otherwise have or hereafter acquire under any statute, provision of the Articles of Incorporation, By-laws, agreement, contract,
vote of stockholders or disinterested directors or otherwise.

 

    	6

    	 

    

 

5. Additional
Indemnification. The Corporation may, by action of its Board of Directors, provide indemnification to such of the directors,
officers, employees and agents of the Corporation to such extent and to such effect as the Board of Directors shall determine
to be appropriate and authorized by the NRS.

 

6. Effect
of Amendments. Neither the amendment, change, alteration nor repeal of this ARTICLE NINTH, nor the adoption of any provision
of this Articles of Incorporation or the By-laws of the Corporation, nor, to the fullest extent permitted by NRS, any modification
of law, shall eliminate or reduce the effect of this ARTICLE NINTH or the rights or any protection afforded under this ARTICLE
NINTH in respect of any acts or omissions occurring prior to such amendment, repeal, adoption or modification.

 

TENTH:

 

1. Corporate
Opportunity. In recognition of the fact that the Corporation and its directors, officers and stockholders, acting in their
capacities as such, currently engage in, and may in the future engage in, the same or similar activities or lines of business
and have an interest in the same areas and types of corporate opportunities, and in recognition of the benefits to be derived
by the Corporation through its continued contractual, corporate and business relations with such persons, the provisions of this
ARTICLE TENTH are set forth to regulate and define the conduct of certain affairs of the Corporation as they may involve such
directors, officers and employees, acting in their capacities as such. Accordingly, to the fullest extent permitted by applicable
law, no director, officer or stockholder of the Corporation, in such capacity, shall have any obligation to the Corporation to
refrain from competing with the Corporation, making investments in competing businesses or otherwise engaging in any commercial
activity that competes with the Corporation. To the fullest extent permitted by applicable law, the Corporation shall not have
any right, interest or expectancy with respect to any such particular investments or activities undertaken by any of its directors,
officers or stockholders, such investments or activities shall not be deemed wrongful or improper, and no such director, officer
or stockholder shall be obligated to communicate, offer or present any potential transaction, matter or opportunity to the Corporation
even if such potential transaction, matter or opportunity is of a character that, if presented to the Corporation, could be taken
by the Corporation, so long as such transaction, matter or opportunity did not arise solely and expressly by virtue of the director
being a member of the Board of Directors or an officer or an employee of the Corporation (a “Restricted Opportunity”).
In the event that any director, officer or stockholder, acting in his capacity as such, acquires knowledge of a potential transaction,
matter or opportunity which may be a corporate opportunity for the Corporation, but is not a Restricted Opportunity, such director,
officer or stockholders, acting in their capacities as such, shall have no duty to communicate or offer such corporate opportunity
to the Corporation and shall not be liable to the Corporation or its stockholders for breach of any fiduciary duty by reason of
the fact that such director, officer or stockholder, acting in his capacity as such, pursues or acquires such corporate opportunity
for itself, directs such corporate opportunity to another person, or does not communicate information regarding such corporate
opportunity to the Corporation, and the Corporation hereby renounces any interest or expectancy in such corporate opportunity.
In furtherance of the foregoing, the Corporation renounces any interest or expectancy in, or in being offered the opportunity
to participate in, any corporate opportunity covered by, but not allocated to it pursuant to, this ARTICLE TENTH to the fullest
extent permitted by the NRS.

 

    	7

    	 

    

 

2. Confidential
Information. The provisions of this ARTICLE TENTH shall in no way limit or eliminate a director’s, officer’s or
stockholder’s duties, responsibilities and obligations with respect to any proprietary information of the Corporation, including
the duty to not disclose or use such proprietary information improperly or to obtain therefrom an improper personal benefit. Except
as otherwise set forth in this ARTICLE TENTH, this ARTICLE TENTH shall not limit or eliminate the fiduciary duties of any director
or officer or otherwise be deemed to exculpate any director or officer from any breach of his fiduciary duties to the Corporation.
For the avoidance of doubt, nothing contained in this Article TENTH amends or modifies, or will amend or modify, in any respect
any written contractual arrangement between any stockholders of the Corporation or any of their respective Affiliates, on the
one hand, and the Corporation and any of its Affiliates, on the other hand, or any applicable employment or non-competition agreement.

 

3. Amendment.
Notwithstanding anything to the contrary contained in this Articles of Incorporation, this ARTICLE TENTH may only be amended (including
by merger, consolidation or otherwise by operation of law) by the affirmative vote of the holders of at least 80% of the Voting
Stock. Neither the termination, alteration, amendment or repeal (including by merger, consolidation or otherwise by operation
of law) of this ARTICLE TENTH nor the adoption of any provision of this Articles of Incorporation inconsistent with this ARTICLE
TENTH shall eliminate or reduce the effect of this ARTICLE TENTH in respect of any matter occurring, or any cause of action, suit
or claim that, but for this ARTICLE TENTH, would accrue or arise, prior to such termination, alteration, amendment, repeal or
adoption.

 

ELEVENTH: Subject
to applicable law and the terms herein, the Corporation reserves the right to repeal, alter, change or amend any provision contained
in this Articles of Incorporation in the manner now or hereafter prescribed by statute and all rights conferred upon stockholders
herein are granted subject to this reservation. No repeal, alteration or amendment of this Articles of Incorporation shall be
made unless the same is first approved by the Board of Directors of the Corporation pursuant to a resolution adopted by the directors
then in office in accordance with the By-laws and applicable law and thereafter approved by the stockholders as provided in the
NRS.

 

TWELFTH:
The name and mailing address of the Corporation is as follows:

 

Logical
Choice Corporation

c/o
Vert Capital Corp.

10951
W. Pico Blvd. #204

Los
Angeles, California 90064

 

Balance
of this page intentionally left blank

 

    	8

    	 

    

 

IN
WITNESS WHEREOF, the Corporation has caused its corporate seal to be hereunto affixed and this Amended and Restated Certificate
of Incorporation to be signed by its duly authorized officer and as approved by the Board of Directors and sole stockholder of
the Corporation on January 19, 2015.

 

	 	Logical
    Choice Corporation
	 	 	 
	 	By:	/s/
    Sheri Lofgren
	 	Name:	Sheri
    Lofgren
	 	Title:	Chief
    Financial Officer

 

    	

    	 

    

 

Exhibit
D

 

CAPITALIZATION
OF

LOGICAL
CHOICE CORPORATION

(A
Nevada Corporation)

 

	Name of Owners of Company Class A Common Stock	 	Share No.	 
	VERT CAPITAL CORPORATION	 	 	16,000,000	 
	The Following Persons and Entities Designated by Vert Capital Corporation:	 	 	 	 
	Lackamoola, LLC	 	 	320,000	 
	Elliot Weiss	 	 	30,000	 
	Herbert Myers (in exchange for relinquishing Boxlight Trademark	 	 	250,000	 
	Westbourne Holdings Ltd.	 	 	2,250,000	 
	Gross Children Family Trust II	 	 	2,000,000	 
	CAELLM Ventures LLC	 	 	1,500,000	 
	Huston Barnet, Inc.	 	 	1,250,000	 
	Roma Ventures, LLC	 	 	1,000,000	 
	Forbes Henry, LLC	 	 	1,000,000	 
	Name of Owners of Company Class B Common Stock	 	 	0	 
	 	 	 	 	 
	Total	 	 	25,600,000	 
	 	 	 	 	 
	Name of Owners of Series A Preferred Stock	 	Share No.	 
	Logical Choice Corporation (Delaware)	 	 	1,588,464	 
	Approximately 50 former minority stockholders of Logical Choice Technologies, Inc., a Georgia corporation, now inactive (shares to be issued post-IPO)	 	 	911,536	 
	Total	 	 	2,500,000	 
	 	 	 	 	 
	Name of Owners of Series B Preferred Stock	 	Share No.	 
	The four former members of Genesis Collaboration LLC:	 	 	 	 
	Mark Elliot	 	 	401,550	 
	John Cox	 	 	401,550	 
	OSS	 	 	401,550	 
	Renova	 	 	401,550	 
	Total	 	 	1,606,200	 

 

    	 

    	 

    

 

SCHEDULE
1.2(c)

 

Allocation
of the Option Shares and Conversion SharesExecution
Copy

 

STOCK
PURCHASE AGREEMENT

 

by
and among

 

GLOBISENS
SHAREHOLDERS

GLOBISENS
LTD.,

 

and

 

LOGICAL
CHOICE CORPORATION

 

As
of October 21, 2014

 

    	 

    	 

    

 

STOCK
PURCHASE AGREEMENT

 

STOCK
PURCHASE AGREEMENT (this “Agreement”), dated as of October 21, 2014, by and among (i) DOVI BRUKER, an
individual (“Bruker” or the “Majority Globisens Shareholder”) and the other
individuals who have executed this Agreement on the signature page hereof (each a “Minority Globisens Shareholder”
and collectively, the “Minority Globisens Shareholders”); (ii) GLOBISENS LTD., a corporation
organized under the laws of the State of Israel (“Globisens” or the “Company”);
and (iii) LOGICAL CHOICE CORPORATION, a Nevada corporation (“LCC” or the “Buyer”).

 

The
Majority Globisens Shareholder and the Minority Globisens Shareholders are hereinafter sometimes collectively referred as the
“Globisens Shareholders” or “Sellers.” The Globisens Shareholders are hereinafter
sometimes collectively referred to as the “Selling Parties” and the Globisens Shareholders, the Company
and the Buyer are sometimes individually referred to as a “Party” and collectively as the “Parties.”
Capitalized terms used herein but not otherwise defined shall have the meaning ascribed to them as set forth on Annex I,
annexed hereto. It is agreed and acknowledged that each of the Globisens Shareholders is entering into this Agreement severally
and not jointly with the other Globisens Shareholders.

 

WHEREAS,
the Company is engaged in, among other things, the business of designing, developing and selling education technology products
and services (the “Business”);

 

WHEREAS,
upon the terms, in the manner and subject to the conditions set forth in this Agreement, the Globisens Shareholders and the board
of directors of the Company desire to cause to consummate a transaction with the Buyer, pursuant to which the Globisens Shareholders,
as collective owners of 100% of the Company’s outstanding capital stock, will sell all their shareholdings of the Company
at the Closing (as defined below) in consideration for Five Million Two Hundred Fifty Thousand Dollars ($5,250,000), payable in
the manner hereinafter described (the “Transaction”); and

 

WHEREAS,
upon the terms, in the manner and subject to the conditions set forth in this Agreement, the Buyer is willing to acquire all Shares
in the Company.

 

NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be
legally bound hereby, the Parties hereto hereby agree as follows:

 

ARTICLE
I.

THE
TRANSACTION

 

1.1Globisens
Capitalization. 

 

(a)As
of the date of this Agreement, the Globisens Shareholders own 13,901 Ordinary Shares 0.01(NIS) par value per share (the “Ordinary
Shares”) which represent of record and beneficially One Hundred Percent (100%) of the issued and outstanding share capital
of the Company, as described in the capitalization table attached hereto as Annex A and made a part hereof (the
“Capitalization Table”). As used in this Agreement, the term “Fully-Diluted Company Shares”
shall mean the collective reference to (i) all issued and outstanding Company Ordinary Shares, (ii) all issued and outstanding
Company preferred or preference shares (if any), (iii) all Ordinary Shares as may be issuable upon the exercise of all warrants,
stock options or other rights granted to any Person to purchase such Company Ordinary Shares, and (iv) all Company Ordinary Shares
that may be issued upon conversion into Company Ordinary Shares of notes, debentures, preferred stock or other securities convertible
into such Company Ordinary Shares.

 

    	 

    	 

    

 

1.2Acquisition
of Subject Globisens Shares.

 

(a)On
the “Closing Date” (herein defined), the Buyer shall acquire from the Globisens Shareholders, in consideration
for the payment of aggregate amount of USD Five Million ($5,250,000) Dollars (the “Purchase Price”), an
aggregate of Thirteen Thousand Nine Hundred and One (13,901) Company Ordinary Shares representing One Hundred One Percent (100%)
of the Fully-Diluted Company Shares (the “Subject Globisens Shares”). At the Closing (as defined hereinafter)
Buyer shall purchase (i) from Bruker a total of 8,693 Ordinary Shares, representing 62.54% of the Subject Shares, and (ii) from
the Minority Globisens Shareholders, as follows: (A) from Benjamin Kaufman (“Kaufman”) a total of 2,780
Ordinary Shares, representing 20.00% of the Subject Shares, (B) from Alejandro Jose Merikanskas Halpern (“AJ Halpern”)
a total of 1,005 Ordinary Shares, representing 7.23% of the Subject Shares, (C) from Arturo Leon Merikanskanskas Halpern (“AL
Halpern”) a total of 1,005 Ordinary Shares, representing 7.23% of the Subject Shares, and (D) from Judith Anat Herzog
(“Herzog”) a total of 417 Ordinary Shares, representing 3.00% of the Subject Shares. Accordingly, Bruker
shall be entitled to 62.54% of the Purchase Price, Kaufman shall be entitled to 20.00% of the Purchase Price, AJ Halpern shall
be entitled to 7.23% of the Purchase Price, AL Halpern shall be entitled to 7.23% of the Purchase Price and Herzog shall be entitled
to 3.00% of the Purchase Price (for each such Globisens Shareholders, the “Pro Rata Entitlement”).

 

(b)At
the closing of the Buyer’s purchase of the Subject Globisens Shares on the Closing Date (the “Closing”)
and against payment of the Purchase Price, the Company shall deliver to the Buyer share certificates evidencing all of the Subject
Globisens Shares, and upon the due transfer of the Subject Globisens Shares, Buyer shall be registered at the Company’s
Registrar of Shareholders as the legal owner of the Subject Globisens Shares having good and marketable title to the Subject Globisens
Shares, free and clear of all Encumbrances, other than as set forth in Section 1.4 below and the Pledge granted hereunder.

 

    	 

    	 

    

 

1.3Purchase
Price and Payment.The Purchase Price shall be payable to the Globisens Shareholders in full on the Closing Date as follows:

 

(a)The
sum of Two Million Five Hundred Thousand ($2,500,000) Dollars (“Closing Cash Consideration”) shall
be paid at Closing in cash by wire transfer of immediately available funds to the accounts designated by each Globisens
Shareholder (which shall be distributed among such shareholders according to Annex A hereto) according to their
Pro Rata Entitlement ; it being understood by the Parties that (i) the Closing Cash Consideration shall be paid out of the
net proceeds of the “Buyer IPO” described below and (ii) Buyer shall at all times, ensure
sufficient funds to be paid upon exercise of the Put Option (described below); and

 

 (b)The sum of Two Million Seven Hundred Fifty Thousand ($2,750,000) Dollars shall be
paid at Closing by delivery and transfer of an aggregate of Two Million Seven Hundred and Fifty Thousand ($2,750,000) Dollars
of common stock, $0.001 par value per share (the “Buyer Common Stock”). On the Closing Date, Buyer shall
deliver and transfer for the benefit of each of the Globisens Shareholders its applicable “Pro Rata Entitlement” of
Buyer Common Stock as detailed in Annex A attached hereto. Such applicable Buyer Common Stock shall be delivered
to a trustee designated according to the ITA (as defined below) (the “Common Stock Trustee), that number of shares
of the Buyer Common Stock as shall be determined by dividing (i) (USD) $2,750,000, by (ii) the per share price at
which shares of Buyer Common Stock is initially offered to the public in the Buyer IPO (the “Buyer Shares”);
provided, however, that in no event shall the Buyer Shares represent less than 3.437% of the issued and outstanding
“Buyer Fully-Diluted Common Stock” (herein defined) immediately prior to the Buyer IPO, based on a (USD)
Eighty Million Dollar ($80,000,000) valuation of all Buyer Fully-Diluted Common Stock immediately prior to the Buyer IPO (the
“Market Valuation”). In the event that for any reason, the Market Valuation in the Buyer IPO shall be
less than (USD) $80,000,000, the percentage of the Buyer Fully-Diluted Common Stock represented by the Buyer Shares shall be proportionately
increased. The term “Buyer Fully-Diluted Common Stock” shall mean the collective reference to (i) all
issued and outstanding Buyer Common Stock, (ii) all issued and outstanding Buyer preferred or preference shares (if any), (iii)
all Common Stock as may be issuable upon the exercise of all warrants, stock options or other rights granted to any Person to
purchase such Buyer Common Stock, and (iv) all Buyer Common Stock that may be issued upon conversion into Buyer Common Stock of
notes, debentures, preferred stock or other securities convertible into such Buyer Common Stock.

 

(c)
Upon execution of this Agreement Buyer shall wire transfer to Company’s bank account an amount of $44,000 (the “Primary
Company’s Expenses”) in order to pay for the Company’s expenses incurred for the preparation of the “Required
Financial Statements” (defined below) through June 30, 2014 and the Pre-Ruling ( as defined below). In the event that the
Buyer shall require a review of the September 30, 2014 quarterly financial statements of the Company or an audit of the Company’s
fiscal year 2014 financial statements for the Buyer IPO as part of the “Required Financial Statements” (defined herein),
the costs of the review or audit of such Required Financial Statements shall be borne by the Buyer.

 

    	 

    	 

    

 

1.4Put
Option; Lock Up Agreement and Trustee Instructions Agreement. 

 

(a)In
order to secure the value of the Buyer Shares, subject to the terms and conditions of this Section 1.4, on the Closing
Date the Buyer shall grant to the Globisens Shareholders an option (the “Put Option”), exercisable at
any time during the two (2) year period, commencing after two (2) years following the Closing Date and ending four (4) years following
the Closing Date (the “Put Option Period”), to cause the Buyer to redeem and repurchase all or a portion
of the Buyer Shares from each of Globisens Shareholders according to their Pro Rata Entitlement, at a price for each Buyer Share
made subject to such Put Option based on a (USD) Two Million Seven Hundred and Fifty Thousand ($2,750,000) Dollars value for all
of such Buyer Shares (the “Put Option Price”). The Put Option may be exercised at any time or from time
to time, during the Put Option Period, upon thirty (30) days prior written notice to the Buyer given by Bruker as a representative
of the Globisens Shareholders (the “Representative”) on behalf of the Globisens Shareholders.

 

(b)From
the Closing Date to and for two (2) years thereafter and until the commencement of the Put Option Period (the “Lock
Up Period”), unless otherwise approved by the Buyer and the managing underwriter of the Buyer Common Stock in connection
with the Buyer IPO (the “Underwriter”), the Globisens Shareholders shall not sell, transfer, hypothecate
or assign (collectively, “Transfer”) any of their Buyer Shares. Upon the commencement of the Put Option
Period, there shall be no restrictions on Transfer of the Buyer Shares.

 

(c)Notwithstanding
the foregoing or any other provision of this Agreement, in the event that at any time during the Put Option Period all of the
Buyer Shares (i) shall have been registered for resale under the United States Securities Act of 1933, as amended (the “Securities
Act”), or may immediately be resold to the public without restriction pursuant to an applicable exemption from the
registration requirements of the Securities Act (either, the “Salable Shares”), and (ii)
any or all of such Salable Shares have been sold by the Globisens Shareholders at a price per Buyer Share that equals or
exceeds the initial per share offering price in which shares of Buyer Common Stock were sold to the public in the Buyer
IPO (the “IPO Offering Price”), the dollar amount and number of Buyer Shares that Buyer is obligated
to purchase upon exercise of the Put Option shall be reduced by the dollar value of the number of Salable Shares that were sold
by the Globisens Shareholders. For the avoidance of doubt, if (x) the initial per share offering price in which shares of Buyer
Common Stock were sold to the public in the Buyer IPO is $5.00 and the number of Buyer Shares is 550,000 Buyer Shares (valued
at $2,750,000) and (y) the number of Salable Shares sold by Globisens Shareholders is 300,000 Buyer Shares sold at a price of
$7.50 per share (valued at $2,250,000), then the Put Option may only be exercised for 100,000 additional Buyer Shares for $5.00
per share, or $500,000. The remaining 150,000 Buyer Shares would be retained by the Globisens Shareholders.

 

Nothing
contained in this Section 1.4(c) shall require Globisens Shareholders to sell Salable Shares at or above the IPO Offering Price
during the Put Option Period; provided, however, that, if any of the Globisens Shareholders elects, either at the
commencement of or during the Put Option Period, not to sell otherwise Salable Shares at or above the IPO Offering
Price, in lieu of the Buyer being required to repurchase the Buyer Shares upon exercise of the Put Option, the Buyer or its Affiliates
may at any time during the Put Option Period, either prior to or following exercise of such Put Option, shall have the right to
arrange for a third party to purchase in a brokers transaction or otherwise such Salable Shares at a price equal, to or
higher than the IPO Offering Price; in which event, if the Globisens Shareholder(s) shall not sell their Salable Shares
to such third party for cash at the IPO Offering Price, or at a higher price as shall be offered, the Put Option shall expire.

 

    	 

    	 

    

 

(d)In
order to secure the exercise of the Put Option and the payment thereunder, on the Closing Date, (i) the Buyer shall deliver to
Arad & Co. Trust Ltd. attn: Lior Kwintner, Esq. 1 Kermenitzki St., Tel-Aviv 6789901, Israel (the “Trustee”)
the applicable share certificates and executed Transfer Deeds evidencing 100% of the Subject Globisens Shares purchased by the
Buyer at the Closing and (ii) execute a deed of first priority pledge in the form attached hereto as Exhibit 1.5(d)(ii)
(the “Deed of Pledge” or the Pledge”). The Trustee shall hold the Transfer Deeds and Subject Globisens
Shares certificates under a Trustee Instructions Agreement among the Globisens Shareholders, the Company, the Buyer and the Trustee,
in the form annexed hereto as Exhibit 1.4(b) and made a part hereof (the “Trustee Instructions Agreement”).
Such Trustee Instructions Agreement shall provide, inter alia, that in the event that the Put Option shall be exercised and the
Buyer shall, within thirty (30) days from the exercise of the Put Option, fail to redeem and repurchase the Buyer Shares for the
full Put Option Price (“Buyer Repurchase Failure”) then and in such event all Subject Globisens Shares shall
be returned and transferred by the Trustee to the Globisens Shareholders free and clear of all Encumbrances according to their
Pro Rata Entitlement.

 

(e)It
is clarified agreed and understood that in any event, including upon the return and transfer of the Subject Globisens Shares according
to the immediate preceding Section 1.4(d), the Globisens Shareholders shall always retain the full cash portion of the Purchase
Price paid at the Closing. In no event shall the number of Subject Globisens Shares that are subject to the Put Option be reduced
if there shall be a Buyer Repurchase Failure. Additionally, the Trustee Instructions Agreement shall provide that upon timely
payment of the Put Option Price or upon the expiration of the Put Option, all of the certificates evidencing the Subject Globisens
Shares and related Transfer Deeds shall be promptly returned by the Trustee to the Buyer.

 

(c)Subject
to the requirements of the tax laws of the State of Israel, if the Put Option is exercisable, but not exercised during the Put
Option Period, the Buyer Shares shall continue to be held by the Common Stock Trustee until the expiration of four (4) years from
the Closing Date.

 

1.5Closing.

 

(a)
Time and Place of the Closing; Buyer IPO. The closing of this Agreement and the transactions contemplated hereby (the
“Closing”) shall take place on a date (the “Closing Date”) shall be immediately
following the Buyer’s consummation of its initial public offering on The NASDAQ Stock Market or the NYSE:American Stock
Exchange of Buyer Common Stock (the “Buyer IPO”) pursuant to a registration statement on Form S-1 (the
“Registration Statement”) that is declared effective by the United States Securities and Exchange Commission
(“SEC”). The Closing shall take place at the offices of the counsel to the Buyer or remotely via the
exchange of documents and signatures as the Buyer and the Globisens Shareholders mutually agreed upon, in writing. Notwithstanding
the foregoing, the Closing Date shall occur on or before March 31, 2015 (the “Outside Closing Date”),
unless such Outside Closing Date shall be extended by mutual written agreement of Representative and the Buyer.

 

    	 

    	 

    

 

(b)Required
Financial Statements.In connection with the Buyer IPO, the Sellers shall cause the Company to deliver to the Buyer:

 

(i)by
a date which shall be not later than September 30, 2014, the audited balance sheet, statement of operations, statement of cash
flows and statement of stockholders equity of the Company as at December 31, 2012 and December 31, 2013 and for the two fiscal
years the ended (the “2012 and 2013 Financial Statements”);

 

(ii)if
required under Regulation D and Regulation S-X, as promulgated under the United States Securities Act of 1933, as amended, following
the date of this Agreement, the audited balance sheet, statement of operations, statement of cash flows and statement of stockholders
equity of the Company as at December 31, 2014 and for the fiscal year the ended (the “2014 Financial Statement”
and together with the 2012 and 2013 Financial Statements, the “Audited Financial Statements”); and

 

(iii)the
comparative unaudited financial statements of the Company for the comparative nine month periods ended September 30, 2013 and
September 30, 2014 (the “Unaudited Financial Statements”), which Unaudited Financial Statements shall
be updated by the Company to a date which shall be 45 days prior to the effective date of the Registration Statement

 

The
Audited Financial Statements and the Unaudited Financial Statements are collectively referred to in this Agreement as the “Required
Financial Statements”). Such Required Financial Statements shall include a balance sheet, statement of income and
statement of cash flows and the Audited Financial Statements shall be accompanied by the audit report of an accounting firm that
is qualified to audit financial statements of United States publicly traded companies.

 

(c)Tax
Pre-Ruling.The Transaction contemplated herein is subject to the grant prior to the Closing Date of a tax pre-ruling by
the ITA according to Section 104H of the Israeli Income Tax Act (the “Pre-Ruling”). The parties hereto acknowledge
and agree that there is no assurance that such Pre-Ruling shall be granted.

 

(d)Deliveries
and Transactions at the Closing. At the Closing, the following transactions shall occur simultaneously (no transaction shall
be deemed to have been completed or any document delivered until all such transactions have been completed and all required documents
delivered):

 

(i)
Share Transfer Deed. Share Transfer Deed in respect of the Subject Globisens Shares, effectuating the transfer thereof
to the Buyer, in the form attached hereto as Exhibit 1.5(d)(i), shall be signed by the each Globisens Shareholder
and the Buyer (the “Deed”); according to Section 1.4(b), Buyer shall sign a new transfer Deed to be deposited
with the Trustee;

 

    	 

    	 

    

 

(ii)Deed
of Pledge. Deed of Pledge and certificates to be dully issued to the Registrar of Pledges in Israel, in the forms attached
hereto as Exhibit 1.5(d)(ii), shall be executed by the applicable parties. Buyer shall provide certified and notarized
copies (from its state of incorporation) of (i) Buyer’s certificate of incorporation, and (ii) Buyer’s Good Standing
certificate, valid as of Closing Date;

 

(iii)Share
Certificates; Registration. The Company shall provide the Buyer with a validly executed share certificate in
the form attached hereto as Exhibit 1.5(d) (iii), in the name of Buyer reflecting the Subject Globisens Shares being
purchased by the Buyer on the Closing Date, and the Company shall register the allotment of such Shares in the Company’s
shareholders register including an indication of the pledge of such shares, together with completed notice of such issuance to
the Israeli Registrar of Companies acceptable for filing after the Closing.

 

(iv)Board
Resolutions. The Company shall provide the Buyer with a copy of duly executed resolutions of the Board, in the form attached
hereto as Exhibit 1.5(d)(iv), by which, inter alia (a) the Board recommends to the Company’s shareholders
to replace the current Articles of Association of the Company with the Amended Articles (as defined below), (b) the board authorizes
the sale and transfer of the Subject Globisens Shares in accordance with and subject to, the terms of this Agreement (at the Closing).

 

(v)Shareholders
Resolution. The Company shall provide Buyer with a copy of duly executed resolutions of the Company’s shareholders in
the form attached hereto as Exhibit 1.5(d)(v), by which, inter alia, the resolutions of the Board referred to in
Section 1.5(b)(iv) shall have been approved,

 

(vi)Amended
Articles.The Shareholders resolution referred to in Exhibit 1.5(b)(v) shall also approve (A) replacing the current Articles
of Association of the Company with new Articles of Association (“Amended Articles”) in the form attached hereto
as Exhibit 1.5(d)(vi) and (B) the terms of Bruker’s new Employment Agreement.

 

(vii)Required
Financial Statements. The Company shall have previously timely provided the Buyer with the Required Financial Statements.

 

(viii)Pre-Ruling;
Withholding Tax. The Tax Pre-Ruling shall have been granted by the Israeli income tax authorities (“ITA”)
and each Globisens Shareholders shall provide Buyer and the Company with a duly issued written confirmation from the Israeli income
tax authorities (“ITA”) of an exemption from deduction at source with respect to the Buyer Shares portion of
the Purchase Price.

 

(ix)Payment
of the Closing Cash Consideration. The Buyer will pay the Closing Cash Consideration ($2,500,000) to each of Globisens Shareholders
according to Annex A by wire transfer of immediately available funds to each Globisens Shareholder bank account, in accordance
with the details specified for each such shareholder in Exhibit 1.5 (d) (ix) (“Transfer Instructions”).

 

    	 

    	 

    

 

(x)
Delivery of Buyer Common Stock. Buyer shall deliver to each Globisens Shareholder, stock certificates registered in the
name of each of the Globisens Shareholders or the Common Stock Trustee and evidencing his or its Pro Rata Entitlement of Buyer
Common Stock. The Buyer Common Stock shall be accompanied by a separate stock power, duly executed in blank by each Globisens
Shareholder, to be delivered by the Common Stock Trustee to the Buyer if the Put Option is exercised pursuant to Section 1.4 of
this Agreement. Similarly, the Buyer Shares shall be delivered to the Common Stock Trustee to be held pursuant to Section 1.4(c)
of this Agreement.

 

(xi)Employment
of Bruker. On the Closing Date, Dovi Bruker and the Company shall amend Bruker’s employment terms and enter into a new
employment agreement in the form attached hereto as Exhibit 1.5(d)(xi) (the “Bruker Employment Agreement”).

 

(xii)Execution
of Agreements. The agreements and documents attached hereto as Exhibits, shall have been executed and delivered by the applicable
parties thereto

 

(e)It
is agreed that all Annexes and/or Exhibits which are not attached to this Agreement upon signing, shall be completed by the Parties
and be attached hereto until Closing.

 

ARTICLE
II.

INTERIM
PERIOD 

 

2.1Conduct
of the Company. Except as (i) is expressly contemplated by this Agreement, (ii) may be required by applicable law, or
(iii) may be agreed in advance and in writing, between Buyer and the Representative of the Globisens Shareholders, or, if under
applicable law the decision is taken solely at the Board level, the approval of the directors appointed by Bruker, until the expiration
of the Put Option, the Company shall conduct its business in the ordinary course and, to the extent consistent therewith, shall
use commercially reasonable efforts to preserve intact its business organizations and relationships with customers, suppliers,
legal counsel, distributors, creditors, lessors, unions, employees and business associates in all material respects. Without limiting
the generality of the foregoing, subject to the exceptions set forth in clauses (i) through (iii) above, from the Closing Date
until the earlier of (a) the payment according to the Put Option or (b) the expiration of the Put Option (the “Interim
Period”), without the prior written approval of the Representative, the Company shall not:

 

(a)amend
or otherwise modify its Amended Articles;

 

(b)(i)
redeem, repurchase or otherwise acquire any of its share capital or other securities, (ii) issue, sell, pledge, dispose of or
encumber any share capital, or securities convertible into or exchangeable for any share capital, or (iii) split, combine or reclassify
any of its share capital (iii) register any transfer of the Subject Globisens Shares or new Encumbrance of such Shares (other
than to the benefit of Globisens Shareholders according to the terms of this Agreement);

 

(c)merge
or consolidate with, or acquire all or substantially all of the assets of any business or any corporation, partnership, joint
venture, association or other business organization or division thereof; or effect an acquisition of shares or assets (including
by way of merger) of another company;

 

    	 

    	 

    

 

(d)sell,
lease, license or otherwise distribute or dispose of any material assets or property, except the sale of inventory in the ordinary
course of business;

 

(e)(i)
incur, assume, guarantee or modify any indebtedness for borrowed money in excess of $100,000, individually or in the aggregate,
or (ii) create, incur or suffer to exist any Encumbrance upon any of its assets or properties in excess of $100,000, individually
or in the aggregate, except in the ordinary course of business consistent with past practice;

 

(f)transfer
or license to any third party or otherwise extend, amend or modify any rights to any Company IP, other than non-exclusive licenses
to the extent such licenses are an integral part of the sale of inventory in the ordinary course of business or pursuant to any
Company Contract (that has been made available to Buyer prior to the date hereof);

 

(g)change
the manufacturer/production facility of the Company;

 

(h)increase
the size of the Board or change the composition of the Board;

 

(i)effect
any dissolution, liquidation or other winding up of the Company or the cessation of all or a substantial part of the business
of the Company;

 

(j)except
for a material breach by Bruker of his obligations and agreement under the Bruker Employment Agreement, appoint or remove the
Company’s CEO;

 

(k)change
or and/or effect any deviation therefrom from the 2 year annual operating plan and budget previously furnished by the Company
to the Buyer.

 

(l)declare
or pay any cash dividends or make any cash distributions to its shareholders .

 

2.2Other
Definitions.Unless otherwise defined in the body of this Agreement, all other capitalized terms shall have the same
meaning as they are defined on Annex I, annexed to this Agreement and made a part hereof.

 

ARTICLE
III.

REPRESENTATIONS
AND WARRANTIES OF THE COMPANY AND BRUKER

 

Each
of the Company and Bruker (collectively, the “Article III Parties”) do hereby jointly and severally make the
following representations and warranties to the Buyer; provided, however, that except for the representations and warranties
set forth in Section 3.1, Section 3.2 and Section 3.3 (all of which shall survive the Closing), all of the other representations
and warranties of the Company and Bruker shall terminate as at the Closing Date and be of no further force or effect. The representations
and warranties of the Company and Bruker contained in Sections 3.1 through 3.3 shall survive Closing indefinitely.

 

    	 

    	 

    

 

3.1Due
Organization and Qualification. The Company is a corporation, duly organized, validly existing and in good standing under
the laws of the State of Israel and has the power and lawful authority to own, lease and operate its assets, properties and business
and to carry on its Business as now conducted. The Company is qualified to transact business and is in good standing in each jurisdiction
in which the nature of its business or location of its property requires such qualification.

 

3.2Authority
to Execute and Perform Agreements. The Company has the full legal right and power and all authority and approval required
to enter into, execute and deliver this Agreement and all other “Transaction Documents” and to perform
fully its obligations hereunder and thereunder. The execution and delivery of this Agreement and the Transaction Documents to
which the Company is a party and the consummation by the Selling Parties of the transactions contemplated hereby and thereby have
been duly and validly authorized by all necessary Company’s corporate actions. This Agreement and the Transaction Documents
have all been duly executed and delivered and are the valid and binding obligations of the Article III Parties enforceable against
them in accordance with their terms, except as may be limited by bankruptcy, moratorium, insolvency or other similar laws generally
affecting the enforcement of creditors’ rights.

 

3.3Ownership
of Company Ordinary Shares.

 

(a)According
to the Capitalization Table attached hereto, the Globisens Shareholders are or until the Closing shall be, the record and beneficial
owner of all and not less than all of the Company Shares; and the Subject Globisens Shares represent and will represent one hundred
percent (100%) of the Fully-Diluted Company Ordinary Shares that is issued or issuable as at the date of this Agreement and will
be issued and outstanding as at the Closing Date.

 

3.4
Tax Matters.

 

(a)All
Tax Returns with respect to the Company that are required to be filed before the Closing Date, have been or will be filed, the
information provided on such Tax Returns is or will be complete and accurate in all material respects, and all Taxes shown to
be due on such Tax Returns have been or will be paid in full, to the extent that a failure to file such Tax Returns or pay such
Taxes, or an inaccuracy in such Tax Returns, could result in the Buyer being liable for such Taxes or could give rise to a Lien
on the Company Ordinary Shares.

 

(b)There
is no pending or, to the Knowledge of the Article III Parties, threatened action, audit, proceeding, or investigation by any taxing
authority with respect to the assessment or collection of Taxes of the Company.

 

(c)The
Company’s tax benefits and terms granted under its tax scheme as a “beneficiary plant” are described in Schedule
3.4.(c) attached hereto.

 

3.5Compliance
with Laws; Permits.

 

(a)To
the Knowledge of the Article III Parties, the Company has not violated any Laws, which violation has had or is reasonably expected
to have a material adverse effect on the Company. To the Knowledge of the Article III Parties, the Company has not made any illegal
payment to officers or employees of any Governmental or Regulatory Authority, or made any payment to customers for the sharing
of fees or to customers or suppliers for rebating of charges, or engaged in any other reciprocal practices that violate any Laws,
or made any illegal consideration to purchasing agents or other representatives of customers in respect of sales made or to be
made by the Company. The Company is not aware of facts that (with or without notice or lapse of time, or both) could result in
the Company being in violation of any Law.

 

    	 

    	 

    

 

3.6No
Breach. The Globisens Shareholders’ execution, delivery and performance of this Agreement and the Transaction Documents
and the consummation of the transactions contemplated hereby and thereby will not violate, conflict with or otherwise result in
the breach or violation of any of the terms and conditions of, result in a modification of the effect of or constitute (or with
notice or lapse of time or both would constitute) a default under (i) the Company’s Articles of Association ; (ii) to its
knowledge, any Contract to which the Company or the Company Stockholders are a party or by or to which it or any of their assets
are bound or subject; or (iii) to its knowledge, any Permit.

 

3.7Litigation.
Except as set forth on Schedule 3.7, neither the Company nor, to the Knowledge of the Article III Parties, any of its officers,
directors or employees is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree
of any court or government agency or instrumentality (in the case of officers, directors or employees, such as would affect the
Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate.

 

3.8Employment
Matters. Except as set forth on Schedule 3.8, the Company is not a party to any employment agreement, work-for-hire
agreement or collective bargaining agreement.

 

3.9Contracts.All
material Contracts binding upon the Company that are set forth on (or required to be set forth on) Schedule 3.9 and on
other Schedules hereto have been delivered or made available to the Buyer (or where a Contract is other than in writing, Schedule
3.9 contains a summary of the material terms of such Contract) .

 

3.10Title
to Assets.Except as disclosed on Schedule 3.10, the Company owns outright and has good and marketable title
to, or a valid leasehold interest in, all of its assets, free and clear of all Encumbrances. On the Closing Date, all of the assets
and properties of the Company shall be free and clear of all Encumbrances.

 

3.11Condition
and Sufficiency of Equipment.All of the computers, servers and other equipment used by the Company in the operation
of its Business (the “Equipment”) are in the reasonable judgment of the Company, in good operating condition
and sufficient to enable the Company to conduct its Business as presently conducted.

 

    	 

    	 

    

 

3.12Third
Party Products. Schedule 3.12 sets forth a true and complete list of all products or services of the Company, which
relate to the Company’s Business, currently being developed, sold or offered for sale by the Company which have been developed
for others by Persons other than the Company (the “Third Party Products”).

 

3.13Customer
and Supplier Lists.

 

(a)Attached
to Schedule 3.13(a) is a true and correct list of the Key Customers and Key Suppliers as of the date of this Agreement.
Such customer list accurately contains the name and address, contract expiration date for each Key Customer. The Company has not
licensed, sold or granted any rights to any Person to use any of such lists. The supplier list accurately contains the name and
address, contract expiration date for each Key Supplier.

 

(b)
Except as set forth on Schedule 3.13(b), to the Knowledge of the Article III Parties, there has been no written notice
that any material customer or supplier of the Company: (i) intends to terminate its agreements with the Company, or otherwise
modify its relationship with the Company, or (ii) that the acquisition of the Company Ordinary Shares by the Buyer will materially
and adversely affect the relationships of the Buyer (as successor to the Business) with such customers or suppliers.

 

3.14Operation
of the Business. Except as set forth on Schedule 3.14 in connection with this Agreement or in connection with the
businesses, the Company has not since June 30, 2014:

 

(a)except
for content or Equipment or inventory acquired in the Ordinary Course, made any acquisition of all or any part of the assets,
properties, capital stock or business of any other Persons or made any commitments to do any of the foregoing;

 

(b)except
in the Ordinary Course, made any sale, assignment, transfer or license of any Products;

 

(c)except
in the Ordinary Course, entered into or amended, or agreed to enter into or amend any Contract to which it is a party or to which
it or its assets or properties related to the Company’s Business are bound or subject;

 

(d)Except
as provided otherwise provided in this Agreement, hired, or agreed to hire, any Person to perform material services in connection
with the Company’s Business; entered into or amended, or agreed to enter into or amend, any employment agreement of any
employee; made or agreed to make any material payment or commitment to pay severance or termination pay to any of its officers,
directors, employees, consultants, agents or other representatives;

 

(e)terminated
or agreed to terminate, or failed to renew, or received any written threat (that was not subsequently withdrawn) to terminate
or fail to renew, any Contract that is or was material to its assets, properties, business, operations or condition (financial
or otherwise) relating to the Business;

 

    	 

    	 

    

 

(f)suffered
or incurred any damage, destruction or loss (whether or not covered by insurance) materially adversely affecting the assets, properties,
business, operations, condition (financial or otherwise) or prospects of the Business;

 

(g)Except
as provided in elsewhere in this Agreement, established or increased any bonus, commission, insurance, retention, deferred compensation,
pension, retirement, profit sharing, stock option (including the granting of stock options, performance awards or restricted stock
awards) or other employee benefit plan or arrangement, increased any salary or otherwise increased the compensation payable to
or to become payable to any Employee;

 

(h)entered
into any employment or severance agreement with any current or former employee providing services with respect to the Business;

 

(i)failed
to make any payment to any creditor as they have become due and payable;

 

3.15Financial
Statements, Business Plan and Projections. The Company has supplied or will supply the Buyer according to this Agreement
with (i) the unaudited financial statements of the Company, consisting of its balance sheet, statement of operations and statement
of cash flows, as of December 31, 2012 and December 31, 2013, and for the two fiscal years then ended (the “Annual Financial
Statements”) and the unaudited financial statements for the comparative nine month periods ended September 30, 2013
and September 30, 2014 (the “Interim Financial Statements”). The Annual Financial Statements have or when delivered,
will have (i) been prepared in accordance with US GAAP or International Financial Reporting Accounting Standards (“IFRAS”),
(ii) reflect all assets, liabilities and results of operations of the Company as at and for the fiscal periods applicable thereto
as required in accordance with US GAAP or IFRAS. On or before the Closing Date, the Company shall furnish the Buyer with the Required
Financial Statements, as provided elsewhere in this Agreement. The Buyer acknowledges that the Company has furnished to the Buyer
the business plan and projections of the Company for the balance of 2014. In addition to the foregoing the Globisens Shareholders
shall cause the Company to provide the Buyer with the “Required Financial Statements” (herein defined).

 

3.16Intellectual
Property.

 

(a)Schedule
3.16(a) sets forth, with respect to the Company, a complete and accurate list of all “Intellectual Property” (as
that term is defined on Annex I to this Agreement) which is owned, licensed, leased or otherwise used by the Company.

 

(b)Schedule
3.16(b) sets forth a complete and accurate list of all material agreements to which the Company is a party or otherwise bound
(i) granting or obtaining any right to use or practice any rights under any Intellectual Property or (ii) restricting the rights
of the Company to use any Intellectual Property, including license agreements, development agreements, distribution agreements,
settlement agreements, consent to use agreements, and covenants not to sue (collectively, the “License Agreements”).
The License Agreements are valid and binding obligations of all Parties thereto, enforceable in accordance with their terms, and,
to the Knowledge of the Article III Parties, there exists no event or condition which will result in a violation or breach of,
or constitute (with or without due notice of lapse of time or both) a default by any party under any such License Agreement. The
Company has not licensed or sublicensed its rights in any Intellectual Property other than pursuant to the License Agreements.

 

    	 

    	 

    

 

(c)Except
as set forth on Schedule 3.16:

 

(i)The
Company owns, or has a valid right to use, free and clear of all Encumbrances, all of the Intellectual Property.

 

(ii)The
Intellectual Property owned by the Company, and to the Knowledge of the Article III Parties, any Intellectual Property used by
the Company, is subsisting, in full force and effect, has not been cancelled, expired, or abandoned, and is valid and enforceable.

 

(iii)There
is no pending or, to the Knowledge of the Article III Parties threatened, claim, suit, arbitration or other adversarial Legal
Proceeding before any court, agency, arbitral tribunal, or registration authority in any jurisdiction (A) involving the Intellectual
Property owned by the Company, or, to the Knowledge of the Article III Parties, the Intellectual Property licensed to the Company,
(B) alleging that the activities or the conduct of the Company’s Business do, or will, infringe upon, violate or constitute
the unauthorized use of the intellectual property rights of any third party or (C) challenging the ownership, use, validity, enforceability
or registrability of any Intellectual Property owned by the Company.

 

(iv)To
the Knowledge of the Article III Parties the conduct of its Business does not infringe upon (either directly or indirectly such
as through contributory infringement or inducement to infringe) any intellectual property rights owned or controlled by any third
party. To the Knowledge of the Article III Parties, no third party is misappropriating, infringing, or violating any Intellectual
Property owned or used by the Company and no such claims, suits, arbitration or other adversarial proceedings which have been
brought against any third party by the Company remain unresolved.

 

(v)The
Company has taken all necessary measures to protect the confidentiality of its Trade Secrets, including (i) requiring each individual
person employed by the Company as of the Closing Date to execute an Employee Confidentiality Agreement, the form of which has
been furnished to Buyer. To the knowledge of the Company, no Trade Secrets have been disclosed or authorized to be disclosed to
any third party other than pursuant to a non-disclosure agreement. To the knowledge of the Company, no party to any non-disclosure
agreement relating to its trade secrets is in breach or default thereof.

 

3.17Full
Disclosure. The Company has made available to Buyer all the information reasonably available to the Company that the Buyer
has requested for deciding whether to acquire the Subject Globisens Shares, all such information has been provided to Buyer’s
satisfaction. To the Knowledge of the Article III Parties, all documents and other papers delivered to the Buyer by or on behalf
of the Company in connection with this Agreement and the transactions contemplated hereby are true, complete and authentic. To
the Knowledge of the Article III Parties, such documents and this Agreement do not contain any untrue statement of a material
fact and do not omit to state any material fact necessary to make the statements made, in the context in which made, not false
or misleading.

 

    	 

    	 

    

 

3.18No
Broker. Except as set forth on Schedule 3.18 hereto, to the Company’s knowledge no broker, finder, agent
or similar intermediary has acted for or on behalf of the Globisens Shareholders in connection with this Agreement or the transactions
contemplated hereby, and no broker, finder, agent or similar intermediary is entitled to any broker’s, finder’s or
similar fee or other commission in connection therewith based on any agreement, arrangement or understanding with the Globisens
Shareholders or any action taken by the Globisens Shareholders.

 

ARTICLE
IV.

REPRESENTATIONS
AND WARRANTIES OF THE MINORITY 

GLOBISENS
SHAREHOLDERS 

 

Each
of the Minority Globisens Shareholders severally and not jointly, represents and warrants to the Buyer; which representations
and warranties shall survive the Closing indefinitely:

 

4.1
Due Organization. If it is a corporate entity, it is duly organized, validly existing and in good standing under
the laws of the jurisdiction of its operation and it has the corporate power and lawful authority to own its assets and properties
and to carry on its business as now conducted.

 

4.2Ownership
of Company Ordinary Shares.

 

(a)According
to the Capitalization Table attached hereto as Annex A, it is or until the Closing he or it shall be, the record
and beneficial owner of such number of Ordinary Shares as described in the Capitalization Table.

 

(b)All
of the Company Ordinary Shares owned by such Minority Globisens Shareholder are owned free and clear of all Encumbrances and may
be transferred and sold to the Buyer pursuant to this Agreement and the Articles of Association of the Company.

 

4.3Authority.
If a corporate entity, it has the full corporate power and authority to execute and deliver this Agreement and to consummate the
transactions contemplated hereby. The execution and delivery of this Agreement and any other Transaction Document to which it
is a party and the consummation by such Minority Globisens Shareholder of the transactions contemplated hereby have been duly
and validly authorized by all necessary corporate action, and no other corporate proceedings on the part of such Minority Globisens
Shareholder is necessary to authorize this Agreement or any Transaction Document to which it is a party or to consummate the transactions
so contemplated.

 

    	 

    	 

    

 

ARTICLE
V.

REPRESENTATIONS
AND WARRANTIES OF BUYER

 

The
Buyer hereby represents and warrants to the Globisens Shareholders and to the Company, as of the date hereof (except as to any
representation or warranty which specifically relates to another date) and as of the Closing Date and until the end of the Put
Option Period, as follows:

 

5.1Due
Organization. The Buyer is a corporation duly organized, validly existing and in good standing under the laws of the State
of Nevada, and has the corporate power and lawful authority to own its assets and properties and to carry on its business as now
conducted.

 

5.2Ownership.Vert
Capital Corp. owns a majority of the outstanding shares of Fully-Diluted Common Stock of the Buyer.

 

5.3Authority
Relative to this Agreement and Transaction Documents. The Buyer has the full corporate power and authority to execute
and deliver this Agreement and any Ancillary Agreement to which it is a party, and to consummate the transactions contemplated
hereby and thereby. The execution and delivery of this Agreement and any other Transaction Document to which it is a party by
the Buyer and the consummation by the Buyer of the transactions contemplated hereby and thereby have been duly and validly authorized
by all necessary corporate action, and no other corporate proceedings on the part of the Buyer is necessary to authorize this
Agreement or any Transaction Document to which it is a party or to consummate the transactions so contemplated. This Agreement
and the Transaction Documents to which it is a party have been duly and validly executed and delivered by the Buyer and, assuming
the due authorization, execution and delivery by the Globisens Shareholders and the Company, constitutes a legal, valid, and binding
obligation of the Buyer enforceable against the Buyer in accordance with its terms subject to the effect of applicable bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium, and other Laws affecting creditor’s rights generally and
general equitable principles.

 

5.4Investment
Intent.The Shares to be acquired by the Buyer hereunder will be acquired for investment for the Buyer’s own
account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that the Buyer
has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement,
the Buyer further represents that the Buyer does not presently have any contract, undertaking, agreement or arrangement with any
Person to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Shares to be
acquired hereunder. Buyer has the financial capability to consummate the transactions hereunder and to pay the Globisens Shareholders
the Purchase Price according to the terms of this Agreement.

 

5.5No
Broker. Except as set forth on Schedule 3.18, no broker, finder, agent or similar intermediary has acted for or
on behalf of the Buyer in connection with this Agreement or the transactions contemplated hereby, and no broker, finder, agent
or similar intermediary is entitled to any broker’s, finder’s or similar fee or other commission in connection therewith
based on any agreement, arrangement or understanding with the Buyer or any action taken by the Buyer.

 

    	 

    	 

    

 

5.6Litigation.
Except as set forth on Schedule 5.6, there are no outstanding Orders against or involving Buyer applicable to the operations
of the Buyer, or the Buyer. Except as set forth on Schedule 5.6, neither of the Buyer is now, nor have either of them been
during the one (1) year prior to the date hereof, a party to or, to Buyer’ Knowledge threatened (in writing) with any Legal
Proceeding applicable to the operations of the Buyer’s business. Except as set forth on Schedule 5.6, there is no
dispute with any Person under contract with Buyer in connection with the operations of the Buyer’s business. In the event
of any legal matter disclosed on Schedule 5.6, none of the legal matters set forth on Schedule 5.6, individually
or together with any other, will result in a Material Adverse Change applicable to the operations of the Buyer’s business
or the Company’s Business. Except as set forth on Schedule 5.6, to Buyer’ Knowledge, there is no fact, event
or circumstance that may give rise to any legal matter that would be required to be set forth on Schedule 5.6 if currently
pending or threatened in writing. There are no legal matters pending or, to Buyer’ Knowledge, threatened in writing that
would give rise to any right of indemnification on the part of any past or present director or officer of the Buyer or the heirs,
executors or administrators of such director or officer against the Buyer or any successor to the Buyer’s business.

 

5.7Disclosure
of Information; Due Diligence. The Buyer has had an opportunity to discuss the Company’s business, management, financial
affairs and the terms and conditions of the Shares to be acquired hereunder with the Company’s management and has had an
opportunity to review the Company’s facilities. Buyer is knowledgeable with the business of the Compnay and is entering
into this Agreement and purchase the Subject Globisens Shares “As Is”, without any further representation or warranty
on behalf of Company and Globisens Shareholders other than those specifically set forth in this Agreement.. Buyer have been fully
satisfied with the results of its due diligence review of the Company and its assets and found them to its satisfaction and hereby
fully and unconditionally waive any claims, contentions or demands against Selling Parties, Company and Bruker in relation thereto.

 

5.8Restricted
Securities. The Buyer understands that the Shares to be acquired hereunder have not been, and will not be, registered
under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends
upon, among other things, the bona fide nature of the intent and the accuracy of the Buyer’s representations as expressed
herein. The Buyer understands that the Shares to be acquired hereunder are “restricted securities” under applicable
U.S. federal and state securities laws and that, pursuant to these laws, the Buyer must hold the Shares indefinitely unless they
are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration
and qualification requirements is available. The Buyer further acknowledges that if an exemption from registration or qualification
is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding
period for the Shares, and on requirements relating to the Company which are outside of the Buyer’s control, and which the
Company is under no obligation and may not be able to satisfy. The Buyer understands that no public market now exists for the
Shares, and that there is no assurance that a public market will ever exist for the Shares.

 

    	 

    	 

    

 

5.9Accredited
Investor 5.10. The Buyer is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under
the Securities Act.

 

5.10Buyer
Shares. At the Closing, the Buyer shall have delivered to the Globisens Shareholders (or the Common Stock Trustee) good
and exclusive title to, and all rights in connection with, the Buyer Shares, free and clear of any encumbrances or any restrictions
on the right to vote. At the Closing, all Buyer Shares (a) have been duly authorized and validly issued, (b) are fully paid, and
(c) have been issued in full compliance with (i) all applicable laws and the incorporation documents of the Buyer; and (ii) any
pre-emptive rights or other rights to subscribe for or purchase securities of the Buyer. The Buyer Shares are not subject to any
voting agreement, proxies, trusts or other agreement or understandings.

 

5.11Buyer
Shares Registration. Buyer shall ensure that effective immediately following the commencement of the Put Option Period,
(i) upon the Globisens Shareholders demand, Buyer shall use its reasonably diligent efforts to cause such Buyer Shares to be registered.
The Buyer will not be obligated to effect more than two consummated registrations (other than on Form S-3) under these demand
registration right provisions; (ii) Globisnes Shareholders will have the right to require Buyer to file Registration Statements
of its Common on Form S-3 (or any equivalent successor form); and (iii) the Globisens Shareholders will be entitled to “piggyback”
registration rights on all registration statements of Buyer. All registration expenses (exclusive of underwriting discounts and
commissions), including the fees and expenses of one counsel to represent the holders of Globisens Shareholders, shall be borne
by Buyer. In connection with the foregoing registration, the Buyer and the Globisens Shareholders shall execute and delivery mutual
indemnification agreements in form and content that are acceptable to the parties and typical in connection with the registration
of securities for selling stockholders.

 

ARTICLE
VI.

ADDITIONAL
COVENANTS AND AGREEMENTS

 

6.1Expenses
of Transaction. Other than with respect to the Globisens Shareholders’ expenses hereunder which shall be borne by
the Company and the Primary Company’s Expenses borne by Buyer, the Parties to this Agreement shall each bear their respective
direct and indirect expenses incurred in connection with the negotiation, due diligence, preparation, execution and performance
of this Agreement, the Transaction Documents and the transactions contemplated hereby and thereby, whether or not the transactions
contemplated hereby and thereby are consummated, including, but not limited to, all fees and expenses of brokers, agents, representatives,
counsel and accountants.

 

6.2Certain
Covenants.

 

(a)Non-Compete.
Bruker acknowledges that he has entered into a covenant not to compete with the Company’s Business, all as set forth in
the Bruker Employment Agreement. No other Minority Shareholder of the Company is actively engaged in the management or operation
of the Business of the Company.

 

    	 

    	 

    

 

(b)
Customers of the Business. None of the Parties hereto shall, directly or indirectly, persuade or attempt to persuade any
customer or supplier or prospective customer or supplier of the Company not to hire or do business with the Company or any successor
thereto.

 

(c)Confidential
Information. Each of the Parties hereto shall keep secret and retain in strictest confidence, all confidential matters relating
to the Company, including, but not limited to, “know how”, trade secrets, customer lists, supplier lists, details
of consultant and employment Contracts, pricing policies, operational methods, marketing plans or strategies, product development
techniques or plans, business acquisition plans, technical processes, designs and design projects, processes, inventions, software,
source codes, object codes, systems documentation and research projects and other business affairs related to the Company (collectively
“Confidential Information”), and other than as a result of commercial relations between a Globisens Shareholder
and the Company, shall not disclose them to anyone provided, however, this covenant shall not apply to any information which is
or becomes generally available to the public through no wrongful act of such Party or others. Each Party hereto may disclose Confidential
Information if required to do so in any legally, legal proceedings, subpoena, civil investigative demand or other similar process;
provided, that such Restricted Party (i) provides the Company with prompt notice of such required disclosure so that the Company
may attempt to obtain a protective order, (ii) cooperates with the Company, at the Company’s expense, in obtaining such
protective order, and (iii) only discloses that Confidential Information which it is absolutely required to disclose as advised
by counsel. Any Confidential Information required to be disclosed in any securities filings shall be agreed in advance between
the applicable Parties involved.

 

(d)Rights
and Remedies upon Breach. If a Party breaches, or threatens to commit a breach of, any of the provisions of this Section 6.2,
the other parties shall have the following rights and remedies, each of which rights and remedies shall be independent of the
others and severally enforceable, and all of which rights and remedies shall be in addition to, and not in lieu of, any other
rights and remedies available to the Buyer under law or in equity:

 

(i)Equitable
Remedies. The right and remedy to obtain an injunction against any actual or threatened breach or violation of the covenants
contained in this Section 6.2 and/or the right have the restrictive covenants set forth in this Section 6.2 specifically enforced
by any court having equity jurisdiction, it being acknowledged and agreed that any such breach or threatened breach may cause
immediate and irreparable injury to the Buyer and that money damages alone may not provide adequate remedy; and

 

(ii)Accounting.
The right and remedy to require a Party to account for and pay over to the Company all payments, profits, monies, accruals, increments
or other benefits derived or received by such Party as the result of any transactions constituting a breach of any of the conditions
and provisions of this Section 6.2

 

(f
)Blue Penciling. If any term or other provision of this Section 6.2 is invalid, illegal, or incapable of being enforced
by any rule of law or public policy, all other conditions and provisions of this Section 6.2 shall nevertheless remain in full
force and effect. Upon determination that any term or other provision is invalid, illegal, or incapable of being enforced, the
Parties hereto shall negotiate in good faith to, or the court making such a determination shall, modify this Section 6.2 so as
to effect the original intent of the Parties as closely as possible in an acceptable manner to the end that the transactions contemplated
hereby are fulfilled to the extent possible.

 

    	 

    	 

    

 

6.3Board
of Directors of the Company. On the Closing Date and subject thereto, the Board of Directors of the Company shall consist
of five (5) individuals three (3) of whom shall be designated by the Buyer, Bruker and one (1) additional individual who shall
be designated by Bruker. In the event of a Buyer Repurchase Failure, the Buyer’s nominated Directors shall immediately discontinue
their services to the Company and terminate their position.

 

6.4Due
Diligence Investigation.

 

(a)Between
the date of execution of this Agreement and the Closing Date, the Buyer shall be given an opportunity to conduct a thorough investigation
and analysis of the business, assets, liabilities, financial condition and business prospects of Globisens (the “Due
Diligence Investigation”). In such connection and in order to facilitate such Due Diligence Investigation, Bruker
and other members of Globisens management shall fully cooperate with the Buyer and its representatives, and provide such persons,
during business hours and upon reasonable advance notice, with access to the books and records of Globisens, inspection of its
facilities and permit Buyer and its representatives to interview personnel and other consultants to Globisens.

 

(b)Notwithstanding
anything to the contrary, express or implied, contained in this Agreement, the obligation of the Buyer to consummate the Closing
and purchase the Shares as contemplated herein, shall be subject to Buyer’s completion of its Due Diligence Investigation
until October 31, 2014 (the “Due Diligence Period”) which shall be satisfactory to the Buyer and its representatives,
in the exercise of its and their sole discretion. Until the end of the Due Diligence Period , Buyer will conduct a thorough due
diligence review of the Company and its assets to verify the accuracy and completeness of all representations and warranties made
under Section 3 hereunder. Buyer acknowledges and agrees that upon the end of the Due Diligence Period it shall have verified
the accuracy and completeness of all such representations and warranties and its full and complete satisfaction from the findings
of its review of the Company. Accordingly, effective immediately following the Closing, Buyer releases, and forever discharges
the Company and the Selling Parties, of and from any and all actions, causes of actions claims or demands that may arise in connection
with the accuracy or completeness of any representation or warranty made under Section 3 hereunder, except as otherwise specified
in said Section 3. Neither Buyer nor any party related directly or indirectly to Buyer, shall make any claim (including for Indemnification)
or cause of action against the Company or any Selling Parties or any party related directly or indirectly to any of the Company
or to the Selling Parties, in connection with any representation or warranty or any matter specified thereunder or in connection
with the results of Buyer’s examination and/or review of the Company. 

 

    	 

    	 

    

 

6.5Further
Assurances. Each of the Parties shall execute such documents and other papers and perform such further acts as may reasonably
be required or desirable to carry out the provisions hereof and the transactions contemplated hereby. Each of the Parties shall
use its reasonable efforts to fulfill or obtain the fulfillment of the conditions to the Closing.

 

6.6Examinations
and Investigations. The Buyer acknowledges that prior to the Closing Date, the Buyer, through its employees and representatives,
will have made such investigations of the Company’s Business and its operation and made examination of the books, records
and financial condition of the Company’s Business as the Buyer reasonably considered necessary. Any such examination will
have been made to Buyer’s full satisfaction.

 

6.7Access
to Records. Each Party agrees to provide the other party with reasonable access to the books and records of the other
party related to the Business after the Closing Date for the purpose of preparing tax returns, defending claims or other reasonable
business purposes.

 

6.8Employment
Agreement and Compensation.

 

(a)On
the Closing Date of the purchase of the Subject Globisens Shares, the Company shall enter into a two (2) year employment agreement
with Bruker, who shall continue to serve as the CEO of the Company, in the form of Exhibit 6.8(a), annexed
hereto and made a part hereof (the “Bruker Employment Agreement”).

 

(b)Such
Employment Agreement shall provide, inter alia, that Bruker will be entitled to receive; (i) a base salary of USD one hundred
and forty thousand dollars ($140,000) per year (the “Base Salary”); (ii) a commission equal to Three
Percent (3%) of Company sales, paid quarterly (“Commission”); and (iii) stock options to purchase a
total amount of One Hundred Fifty Thousand (150,000) shares of common stock of Buyer (the “Incentive Stock Option
Shares”) with a two year vesting period, under which fifty Percent (50%) of the Stock Option Shares shall vest at
the end of each anniversary year of employment. Immediately after Closing and the prior to the issuance of the Incentive
Stock Option Shares Buyer shall cause the Company to adopt an Employees Stock Option Plan, execute option agreement with
Bruker and execute any further action and/or document in accordance with Paragraph 102 to the Israeli Tax Ordinance in order to
enable Bruker, in his capacity as Chief Executive Officer of the Company to receive such Incentive Stock Option Shares which shall
be taxed as capital gain.

 

6.9Buyer
IPO.The Buyer shall use its best efforts to consummation the Buyer IPO on the NASDAQ or NYSE: Amex under which it
shall raise an amount enabling the Buyer to finance the Transactions contemplated herein and pay the full Purchase Price by not
later than March 31, 2015, and shall pay all costs and expenses associated therewith. In such connection, Bruker and the Company
shall fully cooperate with Buyer and furnish to the Buyer and its counsel all information reasonably requested by Buyer and its
counsel as shall be required in connection with a United States public offering of securities, including such information concerning
the Company and its executive officers and management that is to be included in the Registration Statement and related prospectus
relating to such Buyer IPO. None of the Globisens Shareholders shall be liable to any representation, warranty or any other information
set forth in any registration statement being published by the Buyer in connection with the Buyer IPO process. However, prior
to filing any Registration Statement or amendment with the SEC, the Buyer shall submit drafts of such document to the Company
for its review and approval and such representation, warranty or any other information as it relates to Globisens and the Buyer
Share ownership shall be approved by the CEO of the Company as such.

 

    	 

    	 

    

 

INDEMNIFICATION

 

6.9Survival.
Except as otherwise expressly provided in this Agreement, all of the representations and warranties of Globisens and Bruker
shall terminate as at the Closing Date and shall thereafter be of no further force or effect. The remaining representations
of any of the Selling Parties shall survive the execution and delivery hereof and the Closing indefinitely. The foregoing shall
not apply to any intentional material misrepresentation of which the Selling Party making such representation had knowledge prior
to the Closing Date and which constitutes or is tantamount to fraud. Except for the representations and warranties set forth in
Sections 5.1, 5.2 and 5.3, which shall survive indefinitely, all of the representations and warranties of the Buyer shall survive
the execution and delivery hereof until immediately following the execution of the Put Option by Selling Parties.. All covenants
and agreements respectively made by the Selling Parties and the Buyer in this Agreement to be performed after the Closing Date
shall survive the Closing and will remain in full force and effect thereafter until (i) in the case of all covenants and agreements
that have specified terms or periods, until the expiration of the terms or periods specified therein; and (ii) in the case of
all other covenants and agreements that do not have specified terms or periods, until the fulfillment thereof.

 

6.10Obligation
of Selling Parties to Indemnify. Subject at all times to the provisions of Sections 7.1 and 7.6 of this Agreement,
from and after the Closing Date, the Selling Parties shall severally and not jointly, indemnify, defend and hold harmless the
Buyer and its directors, officers, employees, Affiliates and assigns (each, a “Buyer Indemnified Party”; notwithstanding
the aforesaid, it is agreed, that Vert shall not be a Buyer Indemnified Party) from and against any losses, liabilities, damages
(including incidental and consequential damages), deficiencies, costs, expenses (including interest, penalties and reasonable
attorneys’ fees and disbursements) or diminution of value (collectively, “Losses”) sustained or incurred
by such Buyer Indemnified Party relating to, caused by or resulting from:

 

(a)to
the extent applicable, any breach of any representation or warranty of the Selling Parties contained in this Agreement; or

 

(b)any
breach of, or failure to satisfy, any material covenant or obligation of the Selling Parties in this Agreement.

 

For
the avoidance of any doubt, Selling Party’s obligation to indemnify Buyer Indemnified Party under this Section 7 shall only
be made with respect to claims or actions or proceedings made only in Israel, according to Israeli law.

 

    	 

    	 

    

 

6.11Obligation
of Buyer to Indemnify. From and after the Closing Date, the Buyer shall indemnify, defend and hold harmless the Company,
the Globisens Shareholders and Selling Parties’ directors, officers, employees, Affiliates and assigns (each, a “Globisens
Shareholders Indemnified Party”) from and against any Losses, liabilities, damages (including incidental and consequential
damages), deficiencies, costs, expenses (including interest, penalties and reasonable attorneys’ fees and disbursements)
or diminution of value sustained or incurred by such Globisens Shareholders Indemnified Party relating to, caused by or resulting
from:

 

(a)any
misrepresentation or breach of warranty of the Buyer contained in this Agreement, contained herein or in any certificate, schedule,
document, or other writing delivered by the Buyer pursuant to this Agreement; or

 

(b)any
breach of, or failure to satisfy, any material covenant, term, condition or obligation of the Buyer in this Agreement or on any
other certificate, document, writing or instrument delivered by the Buyer pursuant to this Agreement

 

6.12Notice
of Third Party Claims to Indemnifying Party. If any Party (the “Indemnitee”) receives
notice of any claim or the commencement of any action or proceeding from a Person not a party to this Agreement with respect to
which another Party (or Parties) to this Agreement is obligated to provide indemnification (the “Indemnifying Party”)
pursuant to Section 7.2 or Section 7.3, the Indemnitee shall promptly give the Indemnifying Party notice thereof.
Such notice shall describe the claim in reasonable detail and shall indicate the amount (estimated if necessary) of the Loss that
has been or may be sustained by the Indemnitee. The Indemnifying Party may elect to compromise or defend, at such Indemnifying
Party’s own expense and by such Indemnifying Party’s own counsel, any such matter involving the asserted Liability
of the Indemnitee. The failure to provide such notice will not affect any rights hereunder except to the extent the Indemnifying
Party is materially prejudiced thereby. If the Indemnifying Party elects to compromise or defend such asserted Liability, it shall
within thirty (30) days (or sooner, if the nature of the asserted Liability so requires) notify the Indemnitee of its intent to
do so, and the Indemnitee shall cooperate, at the expense of the Indemnifying Party, in the compromise of, or defense against,
any such asserted Liability. In such case the Indemnitee may participate, at its own expense, in such defense. In the event that
the Indemnitee determines in good faith that a conflict of interest exists or that there are defenses, claims or counterclaims
available to the Indemnitee that are not available to the Indemnifying Party, then the Indemnitee shall have the option of obtaining
its own counsel for such claim at the Indemnifying Party’s cost and expense. If the Indemnifying Party elects not to compromise
or defend against the asserted Liability, or fails to notify the Indemnitee of its election as herein provided, the Indemnitee
may at the Indemnifying Party’s expense, pay, compromise or defend such asserted Liability. Notwithstanding the foregoing,
neither the Indemnifying Party nor the Indemnitee may settle or compromise any claim over the objection of the other; provided,
however, that consent to settlement or compromise shall not be unreasonably withheld provided, further, that
no Indemnitee shall be required to consent to, and neither the Indemnifying Party nor the Indemnitee shall settle or compromise,
any claim in any manner that, in the reasonable judgment of the Indemnitee or its counsel, will materially adversely affect the
Indemnitee other than as a result of money damages or other money payments that are fully paid by the Indemnifying Party. If the
Indemnifying Party chooses to defend any claim, the Indemnitee shall make available to the Indemnifying Party any books, records
or other documents within its control that are necessary or appropriate for such defense.

 

    	 

    	 

    

 

6.13Notice
of Claims. In the case of a claim for indemnification hereunder that is not a third party claim covered by Section
7.4 hereof, upon determination by an Indemnitee that it is entitled to indemnification, the Indemnitee shall deliver notice
of such claim to the Indemnifying Party, setting forth in reasonable detail the basis of such claim for indemnification (the “Indemnification
Notice”). Upon the Indemnification Notice having been given to the Indemnifying Party, the Indemnifying Party shall
have thirty (30) days in which to notify the Indemnitee in writing (the “Dispute Notice”) that the amount of
the claim for indemnification is in dispute, setting forth in reasonable detail the basis of such dispute. In the event that a
Dispute Notice is not given to the Indemnitee within the required thirty (30) days, the Indemnifying Party shall be obligated
to pay the Indemnitee the amount set forth in the Indemnification Notice within sixty (60) days after the date that the Indemnification
Notice had been given to the Indemnifying Party. In the event that a Dispute Notice is timely given to an Indemnitee, the Parties
hereto shall have thirty (30) days to resolve any such dispute. In the event that such dispute is not resolved by such Parties
within such period, the Parties shall have the right to pursue all available remedies to resolve such dispute.

 

7.6.
Limitations on Indemnity Obligations. Indemnification under this Article VII shall be the sole and exclusive remedy
for the matters listed in Sections 7.2 and 7.3, except in the case of fraud, willful misconduct or intentional misrepresentation.
There shall be no recovery for claims under Sections 7.2(a) or 7.3(a) (except in the case of fraud, willful misconduct
or intentional misrepresentation) unless and until the aggregate amount of Losses of the Indemnitee that may be claimed thereunder
exceeds USD Twelve Thousand Five Hundred Dollars (USD $12,500.00) (the “Threshold”), and once such Threshold
has been reached, the Indemnifying Parties shall be liable to the Indemnitees only for the amount of Losses in excess of the Threshold.
The maximum recovery for claims by the Buyer under Section 7.2(a) or by the Selling Parties under Section 7.3(a)
(except, in either case, in the case of fraud, willful misconduct or intentional misrepresentation) shall be limited USD Five
Hundred Thousand Dollars (USD $500,000) (the “Indemnity Cap”).

 

For
the avoidance of any doubt, any claim made against Buyer as a result of their breach of their commitment to pay the Globisens
Shareholders the Purchase Note, or any part thereof, shall not be limited by the terms of Section 7 whatsoever.

 

ARTICLE
VII.

GENERAL
PROVISIONS

 

7.1Publicity.
No publicity release or announcement concerning this Agreement, the Transaction Documents or the transactions contemplated hereby
and thereby shall be issued without advance approval of the form and substance thereof by the Selling Parties and the Buyer, except
as may otherwise be required by Law (in which case the party making such release or announcement will provide concurrent or, if
practicable, prior notice to the other Parties hereto).

 

    	 

    	 

    

 

7.2Termination.This
Agreement may be terminated at any time prior to the Closing:

 

(a)
by either the Globisens Shareholders (by notice from the Representative) or the Buyer if the Closing shall not have occurred by
the Outside Closing Date;

 

(b)by
the Buyer, upon a material breach of any representation or warranty of the Globisens Shareholders set forth in this Agreement,
or if any representation or warranty of the Globisens Shareholders shall have become untrue prior to the Closing Date resulting
in a breach of one of the conditions to the Closing;

 

(c)
by the Globisens Shareholders, upon a material breach of any representation or warranty of the Buyer set forth in this Agreement,
or if any representation or warranty of the Buyer shall have become untrue prior to the Closing Date resulting in a breach of
one of the conditions to closing; or

 

(d)by
the mutual written consent of the Globisens Shareholders (by notice from the Representative) and the Buyer.

 

If
this Agreement is terminated pursuant to Section 8.2(a) or Section 8.2(d) above or by the GlobisenS
Shareholders’ Representative as a result of the Buyer’s failure to make timely payment of the Purchase Price,
this Agreement shall become null and void, and none of the Parties hereto shall have any further liability hereunder or in
connection with any other Transaction Document. It is also agreed that the Primary Company’s Expenses paid by
Buyer to the Company shall be returned to Buyer only upon and following the Closing Date and consummation of the Buyer IPO
and the transaction hereunder. Notices. All notices and other communications given or made pursuant hereto
shall be in writing and shall be deemed to have been duly given or made on (i) delivery thereof, if by hand; (ii) upon
receipt, if sent by mail (registered or certified mail, postage prepaid, return receipt requested); (iii) on the second
Business Day following deposit, if sent by a recognized overnight delivery service; or (iv) upon transmission, if sent by
facsimile transmission (in each case with receipt verified by electronic confirmation), in each case as follows:

 

	(i)
                                         if to the Buyer, to:
	 	(ii)
    if to the Globisens Shareholders, to:

	 	 	
	Logical
    Choice Corporation	 	Globisens
    Ltd.,
	c/o
    Vert Capital Corp.	 	94
    Derekh Em Hamoshavot, Petah Tikva
	10951
    W. Pico Blvd	 	4970602,
    Israel
	Suite
    204	 	Attn:
    Dovi Bruker
	Los
    Angeles, CA 90064	 	Chief
    Executive Officer
	Telephone:
    (310) 785-6600 	 	Telephone:
	Facsimile
    No.: (310) 785-66164	 	Office:
	Email:
    michael@vertcapital.com	 	Facsimile:
    
		 	Email:
	 	 	 
	with
    a copy to:	 	with
    a copy to:
	 	 	 
	Hunter
    Taubman Weiss LLP	 	Arad
    & Co., Law Offices
	Attn:
    Stephen A. Weiss	 	Lior
    Kwitner, Esq.
	575
    Lexington Avenue, Suite 4027	 	1
    Kermenitzki St., Tel-Aviv 67899,
	New
    York, NY 10022	 	Israel
	Telephone:
    (212) 600-2284	 	Tel.
    +972-3-6246888
	Cell
    phone: (917) 797-0015	 	Fax.
    +972-3-6246999
	Email:
    sweiss@htwlaw.com	 	E-Mail:
    lior@arad-law.com

 

    	 

    	 

    

 

provided,
that each party hereto shall promptly notify the other Parties hereto of any change in its contact information, which revised
contact information shall thereafter be for purposes of this Section 7.2 until further revised.

 

7.3Entire
Agreement. This Agreement (including the Exhibits and Schedules hereto) and the Transaction Documents contain the entire
agreement among the Parties with respect to the purchase of the Company Ordinary Shares and related transactions and supersede
all prior agreements, written or oral, with respect thereto.

 

7.4Waivers
and Amendments. This Agreement may be amended, modified, superseded, cancelled, renewed or extended, and the terms and
conditions hereof may be waived, only by a written instrument signed by the Parties hereto or, in the case of a waiver, by the
party waiving compliance. No delay on the part of any party in exercising any right, power or privilege hereunder shall operate
as a waiver thereof, nor shall any waiver on the part of any party of any right, power or privilege hereunder, nor any single
or partial exercise of any right, power or privilege hereunder, preclude any other or further exercise thereof or the exercise
of any other right, power or privilege hereunder. The rights and remedies herein provided are cumulative and are not exclusive
of any rights or remedies which any party may otherwise have at law or in equity.

 

7.5Exhibits,
Schedules and Annexes. The Exhibits, Schedules and Annexes to this Agreement are a part of this Agreement as if set forth
in full herein. When a reference is made in this Agreement to an Article, Section, Exhibit or Schedule, such reference is to an
Article or Section of, or an Exhibit or Schedule to, this Agreement unless otherwise indicated.

 

7.6Headings.
The headings in this Agreement are for reference purposes only and shall not in any way affect the meaning or interpretation
of this Agreement.

 

7.7Counterparts.
This Agreement may be executed in one or more original or facsimile counterparts, and by the different Parties hereto in separate
counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one
and the same agreement.

 

7.8Construction
and Interpretation. The Parties acknowledge and agree that this Agreement has been freely negotiated and shall be deemed
to have been drafted by the Parties jointly. Accordingly, no court should construe any provision for or against any party as a
result of such party being involved in the drafting of this Agreement.

 

7.9Assignment.
No party may assign or delegate all or any portion of its rights, obligations or liabilities under this Agreement without
the prior written consent of the other Parties to this Agreement;.

 

    	 

    	 

    

 

7.10Parties
in Interest. This Agreement shall be binding upon and inure solely to the benefit of each party hereto, and, except as
otherwise expressly provided herein, nothing contained in this Agreement, express or implied, is intended to or shall confer upon
any other Person any right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

 

7.11Severability.
If any term or other provision of this Agreement is invalid, illegal, or incapable of being enforced by any rule of law or public
policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect. Upon determination
that any term or other provision is invalid, illegal, or incapable of being enforced, the Parties hereto shall negotiate in good
faith to, or the court making such a determination shall, modify this Agreement so as to effect the original intent of the Parties
as closely as possible in an acceptable manner to the effect that the transactions contemplated hereby are fulfilled to the extent
possible.

 

7.12Governing
Law; Forum. This Agreement and shall be governed by the laws of the State of Israel. The Parties hereto do hereby consent
and submit to the exclusive venue and jurisdiction of the State of Israel, the Courts residing in Tel Aviv- Jaffa as the sole
and exclusive forum for such matters of disputes, and further agree that, in the event of any action or suit as to any matters
of dispute among the Parties, service of process may be made upon the other party by mailing a copy of the summons and/or complaint
to the other party at the address set forth herein.

 

[Remainder
of page left blank intentionally; Signature page to follow]

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the Parties have caused their duly authorized representatives to execute this Agreement on the date first above
written.

 

	Buyer:	LOGICAL CHOICE CORPORATION
	 	 	 
	 	By:	/s/
    Mark Elliott
	 	Name:	Mark
    Elliott
	 	Title:	Chief
    Executive Officer
	 	 	 
	Globisens
    Shareholders:	 	 
	 	 	 
	 	 	/s/
    Dovi Bruker
	 	 	DOVI
    BRUKER
	 	 	 
	 	 	/s/
    Benjamin Kaufman
	 	 	BENJAMIN
    KAUFMAN
	 	 	 
	 	 	/s/
    Alejandro Jose Merikanskas Halpern
	 	 	ALEJANDRO
    JOSE MERIKANSKAS HALPERN
	 	 	 
	 	 	/s/
    Arturo Leon Merikanskanskas Halpern
	 	 	ARTURO
    LEON MERIKANSKANSKAS HALPERN
	 	 	 
	 	 	/s/
    Judith Anat Herzog
	 	 	JUDITH
    ANAT HERZOG
	 	 	 
	The
    Company:	GLOBISENS LTD.
	 	 	 
	 	By:	/s/
    Dovi Bruker
	 	Name:	Dovi
    Bruker
	 	Title:	CEO

 

    	 

    	 

    

 

List
of Exhibits and Annexes [to be completed until Closing]

 

	Exhibit
    1.4(b) 	Trustee
    Instructions Agreement	 
	Exhibit
    6.8	Form
    of Employment Agreement	 
	Annex
    A	Capitalization
    Table	 
	Annex
    I	Definitions	 

 

Stock
Purchase Agreement

List
of Exhibits

 

    	 

    	 

    

 

Execution
Copy

 

ANNEX
A

 

GLOBISENS
CAPITALIZATION

 

	At
    Closing with LLC
	Name	 	Title	 	Stock
    	 	%
	Dov
    Bruker	 	Founder
    and CEO	 	8,693	 	62.54%
	Alejandro
    Merikanskas	 	Lender	 	1,005	 	7.23%
	Artoro
    Merikanskas	 	Lender	 	1,005	 	7.23%
	Ben
    Kaufmann	 	Lender	 	2,780	 	20.00%
	Judith
    Herzog	 	Investor	 	 417	 	3.00%
	 	 	 	 	 	 	 
	Total	 	 	 	13,901	 	100.00%

 

    	 

    	 

    

 

Annex
I

 

Definitions

 

(a)Defined
Terms

 

“Affiliate”
means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls,
or is controlled by, or is under Ordinary control with, such Person. The Stockholder is an Affiliate of the Company.

 

“Business
Day” means a day, other than a Saturday or Sunday, on which commercial banks in Los Angeles, California and Tel
Aviv, Israel are open for the general transaction of business. 

 

“Contract”
means any contract, agreement, license, indenture, note, bond, loan, instrument, lease, commitment, work order, task order, purchase
order, statement of work, understanding or other arrangement, whether, express or implied, written or oral.

 

“control”
(including, with correlative meanings, the terms “controlled by” and “under Ordinary control with”), as
applied to any Person, shall mean the possession, direct or indirect, of the power to direct or cause the direction of the management
and policies of such Person, whether through the ownership of voting securities or other ownership interest, by contract or otherwise.

 

“Dollar”,
“USD” or “$” means United States dollars.

 

“Encumbrances”
means any mortgage, pledge, security interest, encumbrance, lien, claim, option, easement, deed of trust, right-of-way, encroachment,
restriction on transfer (such as a right of first refusal or other similar rights, defect of title or charge of any kind, whether
voluntary or involuntary, on any of the assets, properties or securities of the Company, including any conditional sale or other
title retention agreement, any lease in the nature thereof and the filing of, or agreement to give, any financing statement under
the Uniform Commercial Code of any jurisdiction.

 

“GAAP”
shall mean generally accepted accounting principles as are in effect from time to time applied on a consistent basis both as to
classification of items and amounts.

 

“Governmental
or Regulatory Authority” means any court, tribunal, arbitrator, authority, agency, bureau, board, commission, department,
official, regulator, quasi-governmental authority, or other instrumentality of the State of Israel.

 

“Infras”
shall mean international financial reporting accounting standards as are in effect from time to time applied on a consistent basis
both as to classification of items and amounts.

 

Stock
Purchase Agreement

Annex
I -

 

    	 

    	 

    

 

“Intellectual
Property” shall mean all of the following items, along with all income, royalties, damages and payments due or payable
at the Closing or thereafter, including damages and payments for past, present or future infringements or misappropriations thereof,
the right to sue and recover for past infringements or misappropriations thereof and any and all corresponding rights or interests
that, now or hereafter, may be secured throughout the world: (i) patents, patent applications, patent disclosures and inventions
(whether or not patentable and whether or not reduced to practice) and any reissue, continuation, continuation-in-part, division,
revision, extension or reexamination thereof; (ii) trademarks, service marks, trade dress, logos, trade names, together with all
translations, adaptations, derivations, and combinations, including all goodwill associated therewith; (iii) copyrights, registered
or unregistered and copyrightable works; (iv) domain names; (v) mask works; (vi) all registrations, applications and renewals
for any of the foregoing; (vii) trade secrets, (viii) computer software and software systems (including data compilations, databases
and related documentation); (ix) rights of publicity, persona rights or other rights to use indicia of any Person’s personality;
(x) licenses or other agreements to or from third Parties regarding the foregoing; and (xi) all copies and tangible embodiments
of the foregoing (in whatever form or medium).

 

“Key
Customers” mean the 10 largest customers of the Business by Dollar value.

 

“Key
Suppliers” mean the 10 largest suppliers of the Business by Dollar value.

 

“Knowledge”
means the actual knowledge of the Globisens Shareholders or any executive officer or director of the Company, Vert or the Buyer,
as applicable, after due inquiry.

 

“Laws”
(or “Law” where the context requires) shall mean applicable international, multinational, national,
foreign, federal, state, municipal, local (or other political subdivision) or administrative law, constitution, statute, code,
ordinance, rule, regulation, requirement, standard, policy, or guidance having the force of law, treaty, judgment, order, injunction,
award and decree of any kind of nature whatsoever including any judgment or principle of Ordinary law.

 

“Legal
Proceeding” means any action, suit, litigation, investigation or judicial, administrative or arbitration inquiry
or proceeding.

 

“Liability”
means any liability, claim, loss, damage, deficiency, obligation or responsibility, known or unknown, (whether asserted or unasserted,
whether absolute or contingent, whether accrued or unaccrued, whether secured or unsecured, whether liquidated or unliquidated,
and whether due or to become due), including any liability for Taxes, other governmental charges or lawsuits brought, whether
or not of a kind required by GAAP to be set forth on a financial statement.

 

“Licenses”
means all licenses, sublicenses, concessions and other agreements, including all amendments, extensions, renewals, guaranties
and other agreements with respect thereto, pursuant to which the Globisens Shareholders or any Affiliate of the Globisens Shareholders
have licensed any Purchased Asset, including any Intellectual Property.

 

“Material
Adverse Change” means a material and adverse change in (or effect on) the financial condition, properties, assets,
liabilities, rights, obligations, operations or business, of a Person and its Subsidiaries taken as a whole.

 

“Material
Contract” means each Contract to which the Company is a party which requires the payment during the term thereof
in excess of $25,000.

 

Stock
Purchase Agreement

Annex
I -

 

    	 

    	 

    

 

“Order”
means any enforceable award, decision, injunction, judgment, order, ruling, subpoena or verdict entered, issued, made or rendered
by any court, administrative agency, other Governmental or Regulatory Authority or by any arbitrator.

 

“Ordinary
Course” means, with respect to any Person, in the ordinary course of that Person’s business consistent with
past practice, including as to the quantity, quality and frequency.

 

“Permits”
means permits, certificates, licenses, orders, franchises, authorizations and approvals issued or granted by Governmental or Regulatory
Authorities.

 

“Person”
shall mean any person or entity, whether an individual, trustee, corporation, corporate, general partnership, limited partnership,
trust, unincorporated organization, business association, firm, joint venture, governmental agency or authority or any similar
entity.

 

“Tax
Returns” shall mean all returns, declarations, reports, claims for refund, forms, estimates, information returns
and statements required to be filed in respect of any Taxes to be supplied to a taxing authority in connection with any Taxes,
including any schedule or attachment thereto, and including any amendment thereof.

 

“Taxes”
(or “Tax” where the context requires) means all federal, state, county, local, foreign and other taxes
imposed under the laws of the State of Israel (including, without limitation, income, profits, windfall profits, environmental
premium, disability, registration, license, alternative or add-on minimum, stamp, value added, goods and services, estimated,
excise, sales, use, occupancy, gross receipts, franchise, ad valorem, severance, capital levy, production, transfer, withholding,
employment, social security, unemployment compensation, payroll-related and property taxes, import duties and other governmental
charges and assessments, including any Liability of the Company or the Globisens Shareholders, and including deficiencies, interest,
additions to tax or interest and penalties with respect thereto relating to the assets, business or property of the Company with
respect to any period prior to the Closing Date or arising out of the transaction contemplated hereby.

 

“Transaction
Documents” shall mean the collective reference to this Agreement, all Exhibits to this Agreement and all other certificates
and instruments to be executed and delivered by the Parties on the Closing Date, including, without limitation, the Subject Globisens
Shares, the Purchase Note, the Security Agreement, the Pledge and Trust Agreement, and the Employment Agreement.

 

(b)For
the purposes of this Agreement, except to the extent that the context otherwise requires:

 

(i)whenever
the words “include,” “includes” or “including” (or similar terms) are used in this Agreement,
they are deemed to be followed by the words “without limitation”;

 

(ii)the
words “hereof,” “herein” and “hereunder” and words of similar import, when used in this Agreement,
refer to this Agreement as a whole and not to any particular provision of this Agreement;

 

Stock
Purchase Agreement

Annex
I -

 

    	 

    	 

    

 

(iii)all
terms defined in this Agreement have their defined meanings when used in any certificate or other document made or delivered pursuant
hereto, unless otherwise defined therein;

 

(iv)the
definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms;

 

(v)if
any action is to be taken by any party hereto pursuant to this Agreement on a day that is not a Business Day, such action shall
be taken on the next Business Day following such day;

 

(vi)references
to a Person are also to its permitted successors and assigns; and

 

(vii)the
use of “or” is not intended to be exclusive unless expressly indicated otherwise.

 

Stock
Purchase Agreement

Annex
I -

 

    	 

    	 

    

 

Exhibit
1.4(B)

 

TRUSTEE
INSTRUCTIONS AGREEMENT 

 

Stock
Purchase Agreement

Exhibit

 

    	 

    	 

    

 

Exhibit
6.8(A)

 

FORM
OF EMPLOYMENT AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}]]